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Abstract 
The SMC5/6 complex is part of the Structural Maintenance of Chromosomes (SMC) family of 
proteins, which includes condensin and cohesin and whose main function is the regulation of 
chromosomal architecture and organization. While it is known that SMC5/6 participates in 
genome maintenance, how and where the complex operates remains unclear. With the use 
of mouse models our work has revealed that NSMCE2, a SUMO ligase that is an integral 
member of the SMC5/6 complex, suppresses cancer and ageing in mice independently of its 
SUMO ligase activity. At the cellular level, NSMCE2 deficiency leads to severe segregation 
defects and increased recombination rates, which would be consistent with a role of the 
SMC5/6 complex in the resolution of joint DNA molecules before chromosome segregation. 
Besides the overall accelerated ageing that occurs when Nsmce2 is deleted in adult animals, 
we here show that these mice present a distinct phenotype on their kidneys that presents all 
the hallmarks of Karyomegalic interstitial nephritis (KIN). KIN is a progressive kidney disease 
that in humans has been linked either to exposure to Ochratoxin A, a Topoisomerase II 
(TOPOII) inhibitor, or to inherit mutations in FAN1, an endonuclease mainly associated to the 
repair of interstrand cross-links (ICL). Our data suggests that NSMCE2 deficiency leads to 
the accumulation of topological problems, which would ultimately lead to polyploidy and be 
the cause of the karyomegaly. In support of this, NSMCE2 deficiency sensitizes cells to the 
inhibition of TOPOII, and leads to a number of phenotypes that are observed upon TOPOII 
inhibition. In summary, we here present the second mutation that can trigger KIN in 
mammals, and propose that topological problems, rather than deficiencies in ICLs repair, are 
the actual cause of this disease. 
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Presentación 
 
El complejo SMC5/6 pertenece a la familia de proteínas SMC (por sus siglas en inglés: 
Structural Maintenance of Chromosomes), donde también se incluyen cohesina y 
condensina, y cuya principal función es el control de la organización y estructura de los 
cromosomas. Si bien se sabe que SMC5/6 participa en el mantenimiento del genoma, cómo 
y dónde el complejo ejerce su función, no está claro. Utilizando modelos animales, nuestro 
trabajo ha revelado que NSMCE2, una SUMO ligasa integrante del complejo SMC5/6, 
suprime el cáncer y el envejecimiento en ratones independientemente de su actividad como 
SUMO ligasa. A nivel celular la deficiencia en NSMCE2 produce importantes defectos en 
segregación cromosómica y aumenta la frecuencia de recombinación, lo cual explicaría un 
papel del complejo SMC5/6 en la resolución de uniones entre moléculas de DNA antes de la 
segregación. Además del envejecimiento generalizado que ocurre en animales adultos que 
no expresan NSMCE2, aquí también mostramos que estos animales presentan un fenotipo 
particular en sus riñones. En concreto poseen los rasgos característicos de la nefritis 
intersticial cariomegálica o KIN (por sus siglas en inglés: Karyomegalic interstitial nephritis). 
KIN es una enfermedad progresiva de riñón que en humanos se ha relacionado con la 
exposición a ocratoxina A, un inhibidor de la Topoisomerasa II, o a mutaciones en FAN1, 
una endonucleasa asociada principalmente con la reparación de uniones cruzadas entre 
hebras de DNA o “interstrand cross-links” (ICL). Nuestros datos sugieren que la deficiencia 
en NSMCE2 conduce a una acumulación de problemas topológicos que podrían llevar en 
último término a la poliploidía y serían la causa de la cariomegalia. Prueba de ello es que la 
deficiencia en NSMCE2 sensibiliza a las células frente a la inhibición de la Topoisomerasa II 
y produce fenotipos que se observan tras la inhibición de esta enzima. En resumen, en este 
trabajo presentamos la segunda mutación que puede desencadenar nefritis intersticial 
cariomegálica en mamíferos, y proponemos que la causa de la enfermedad es la aparición 
de problemas topológicos más que las deficiencias en reparación de ICL. 
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1 - Maintenance of genomic integrity 
DNA governs many cellular processes and defines the blueprint of proteins and RNAs within 
cells. Unlike any other biological macromolecule DNA cannot be replaced. Therefore, errors 
may have permanent consequences and the inaccurate genetic information will be 
transmitted to the daughter cells (Garinis et al., 2008). Given the importance of preserving 
genomic integrity, cells have evolved several mechanisms to maintain the fidelity of genetic 
information, involving sophisticated machineries to repair the lesions, checkpoint pathways 
and mechanism of DNA damage tolerance (Hoeijmakers, 2009). Failure in these processes 
often leads to pathological conditions such as premature ageing, a variety of inherited 
diseases and predisposition to cancer (Aguilera and Gómez-González, 2008). 
 
1.1 - Sources of DNA damage and the DNA damage response (DDR) 
Around 1000 single-strand breaks and base losses are estimated to occur daily in every cell. 
The total amount of lesions per cell can rise up to 100,000 lesions per day considering other 
types of DNA damages that may occur (Garinis et al., 2008, Lindahl, 1993). Insults to 
genomic integrity can arise from exogenous agents but also from the products of 
endogenous metabolism (Figure 1a). The most frequent source of exogenous DNA damage 
is ultraviolet light (UV). UV-A and UV-B light are not filtered by the ozone layer and they can 
induce a conspicuous number of photoproducts. 100,000 lesions per cell are estimated to 
occur after one hour exposure to strong sunlight (Jackson and Bartek, 2009). DNA integrity is 
also threatened by the exposure to ionizing radiation (IR), which can induce a range of 
lesions, including DNA double strand breaks (DSBs), which are the most toxic of all (Jackson 
and Bartek, 2009). 
Normal cellular metabolism is also a potential DNA damaging source. Although it is required 
to maintain fundamental biological processes, it can contribute to genomic instability in 
various ways. For instance, internal metabolism produces reactive oxygen species (ROS) 
deriving from oxidative respiration and lipid peroxidation, which are radical species that can 
attack DNA (Jackson and Bartek, 2009).  Given the dangerous presence of these 
compounds within the nucleus, it is not surprising that evolution has provided a series of 
ROS caretaking systems to overcome the price of cell own metabolism (Hoeijmakers, 2001). 
Besides ROS, recent findings indicate that the endogenous production of aldehydes can also 
promote crosslinks in both DNA and proteins. For instance, endogenous formaldehyde is 
abundant and ubiquitous within cells. This compound can be produced directly from histone 
demethylation reactions that take place on chromatin, thus posing a direct challenge to 
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genomic integrity (Pontel et al., 2015, Stingele et al., 2016, Rosado et al., 2011). DNA can 
also undergo spontaneous chemical deterioration, thereby, creating abasic sites and 
deamination. The deamination of cytosine, adenine and 5-methylcytosine can convert these 
bases into a miscoding base (e.g. uracil) (Hoeijmakers, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
The consequences of the damage can greatly vary depending on the type, the severity of the 
injury and its localization within the genome. Besides generating point mutations, the hazard 
posed by DNA injuries comes from the potential perturbation of chromatin transactions such 
as transcription and replication. Regarding transcription, lesions can block the transcription 
process, either inactivating the transcribed gene or affecting the transcribed product. When 
Fig. 1 - Sources and repair of DNA damage (Hoeijmakers, 2001) 
a) Common endogenous and exogenous sources of DNA damage and specific repair of such lesions. X-
rays, oxygen radicals, alkylating agents and spontaneous reactions can induce types of DNA damage 
(such as uracil, abasic site, 8-Oxoguanine, ssDNA) that are repaired through the Base Excision Repair 
pathway (BER). UV light and polycyclic aromatic carbons can generate 6-4 photoproduct (6-4 PP), 
cyclobutane pyrimidine dimer (CPD) and bulky adduct that are repaired by the Nucleotide-Excision repair 
pathway (NER). Exposure to X-ray and a certain class of chemotherapeutic drugs (Cisplatin and 
Mitomycin C) can instead lead to Inter-strand crosslink lesions and DSBs that are dealt by the 
Homologous recombination (HR) pathway. In addition, errors introduced by the replication machinery 
are repaired by the mismatch repair pathway. 
b) Possible outcome following the activation of the DNA damage response (DDR). Activation of DDR may 
induce cell cycle arrest in order to provide time for the repair of the lesion. Eventually, the apotosis 
pathway can be activated. When changes in the DNA sequence are not repaired, they persist in the 
genome and can trigger cancer and ageing. 
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interfering with DNA replication, fork stalling can lead to the breakage of the fork, with the 
subsequent risk of genomic rearrangements. 
In order to protect genetic information from genotoxic insults, cells have evolved an 
interwoven and sophisticated DNA repair system. The maintenance of genomic integrity 
includes multiple multistep DNA repair pathways, covering most of the insults that can be 
inflicted to a cell. Most of these repair programs are coordinated though a common signal 
transduction pathway activated by DNA damage and replication stress, and overall known as 
the DNA damage response (DDR) (Harper and Elledge, 2007). Upon activation of the DDR, 
the cell cycle is halted at its various checkpoints (primarily G1 and G2), which arrest the cell 
cycle in order to provide time to repair the lesion.  If the damage is too severe, cells may 
instead choose to activate apoptosis, leading to cell death in a tightly regulated manner 
(Figure 1b) (Hoeijmakers, 2001).  
 
1.2 - Replication stress is a major threat to genomic integrity 
In addition to the spontaneous vulnerability of DNA and the exposure to exogenous and 
endogenous damaging compounds, major injuries can arise during DNA replication itself, 
thus posing at risk the genomic integrity in each cell cycle (Lecona and Fernández-Capetillo, 
2014). The variety of events challenging normal fork progression is known as Replication 
Stress (RS).  
The replisome has to face numerous obstacles, such as DNA modifications, difficult to 
replicate structures or limiting amounts of the nucleotide pool. All these challenges may lead 
to replication fork stalling and accumulation of recombinogenic single stranded DNA 
(ssDNA). Although most of the ssDNA is generated in S-phase, accumulation of ssDNA can 
also occur after DSB resection or at patches generated by double-nicks during Nucleotide 
excision Repair (NER). ssDNA becomes rapidly coated by the ssDNA binding protein RPA 
(Replication protein A). These structures are recognised by the kinase ATR, which is then 
recruited to the lesion by binding to RPA through the ATR interacting protein ATRIP (Figure 
2) (López-Contreras and Fernandez-Capetillo, 2010). At the arrested forks, ATR is activated 
allosterically by interaction with factors such as TopBP1 or ETAA1. Once active, ATR 
phosphorylates multiple factors including the key checkpoint protein CHK1 (Checkpoint 
kinase 1). CHK1 lowers CDK activity thereby preventing the entry into mitosis when DNA has 
not been fully replicated (Lecona and Fernández-Capetillo, 2014, López-Contreras and 
Fernandez-Capetillo, 2010). A failure in this cascade would lead to the presence of 
unreplicated loci in mitosis, leading to major segregation problems and ultimately cell death. 
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Accordingly, death by ATR inhibitors can be rescued by preventing the premature mitotic 
entry induced by these chemicals (Ruiz et al., 2016).  
 
In any case, targeting ATR activity has shown to have potential as an anticancer strategy. 
The idea behind this therapy is that limited ATR activity should be particularly toxic for cells 
presenting high endogenous levels of RS, such as those carting various oncogenic mutations 
(Halazonetis et al., 2008). In support of this view, low levels of ATR prevent the development 
of Burkitt lymphomas induced by MYC in mice (Murga et al., 2011) and ATR inhibitors have 
already showed efficiency in preclinical models of various tumors with high levels of RS such 
as Ewing sarcomas and Acute Myeloid Leukemia (AML) (Nieto-Soler et al., 2016, Morgado-
Palacin et al., 2016). 
 
1.3 - Homologous recombination-mediated repair and processing of Holliday 
junctions  
DSBs represent the most dangerous threat to DNA integrity. This is mostly due to the 
difficulties to repair DSBs compared to other types of DNA damage. In addition, erroneous 
rejoining of the broken ends may result in severe alteration of the genetic information, due to 
loss or amplification of chromosomal regions and translocations (Khanna and Jackson, 
2001). DSBs can occur as a consequence of RS when the replication fork encounters a 
blocking lesion leading to fork collapse. Otherwise, DSBs can arise from the exposure to IR 
and from certain DNA damaging compounds. Moreover, immune cells and gametes use 
Fig. 2 - Activation of the ATR 
pathway (López-Contreras and 
Fernandez-Capetillo, 2010). 
RPA-coated ssDNA, generated from 
DSB resection and stalled replication 
forks, recruits the kinase ATR to the 
site of damage. RPA also recruits 
Rad17 that is responsible for the 
loading of PCNA-like heterodimeric 
ring 9-1-1. This complex then 
activates ATR by allowing the 
interaction of the kinase with 
TopBP1. 
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DSB-intermediates as part of their recombinatorial processes (Shrivastav et al., 2008, 
Khanna and Jackson, 2001). 
DSBs are preferentially repaired by Homologous Recombination (HR), a highly complex and 
precise DNA repair pathway that uses the information of the complementary sequence in the 
other duplex to drive the repair of the broken chromosome (Mimitou and Symington, 2009). 
Since HR uses the replicated chromatin as a template (rather than the homologous 
chromosome to prevent loss of heterozygosity) it is restricted to S and G2 phases of the cell 
cycle. The initial step involves the degradation of the dsDNA by nucleases to generate 3′ 
ssDNA tails (Figure 3), which are rapidly protected by RPA coating. Next, RAD51 assembles 
onto the ssDNA to form a nucleoprotein filament with the assistance of mediator proteins 
such as BRCA2. The RAD51 filament then searches the homologous sequence and 
promotes the invasion of the ssDNA into the homologous targeted region to form a joint 
molecule. After RAD51 removal, DNA polymerases synthesize the missing region by using 
the homologous chromatid as template (Forget and Kowalczykowski, 2010, Mimitou and 
Symington, 2009).  
The switching of strands between chromatids leads to the formation of a cross-stranded 
structure, known as Holliday junction (HJ), that physically links the two recombining DNA 
molecules by a four-way junction (Matos and West, 2014). The physical evidence of 
recombination intermediates was provided for the first time by electron microscopy studies 
conducted in the early 1970 (Doniger et al., 1973, Thompson et al., 1975, Benbow et al., 
1975, Liu and West, 2004). The disentanglement of HJs can lead to crossover or non-
crossover products depending on the pathway that is selected for the repair (Figure 3).  
In somatic cells, HJs are preferentially processed through the dissolution pathway, which 
separates chromatids without the formation of crossover products. The dissolution of the 
linked DNA molecule is achieved by the BTR complex, composed of the helicase BLM, the 
topoisomerase III alpha (TOPOIIIα) and the RecQ-mediated instability factors, RMI1 and 
RMI2. BLM catalyses the migration of a double HJ towards one another, collapsing it into a 
hemicatenane, that is then cleaved and religated  by TOPOIIIα (Swuec and Costa, 2014, 
Cejka et al., 2010). 
If disentanglement cannot be accomplished through the anti-recombinogenic pathway of 
dissolution, a nuclease-dependent pathway, known as resolution, takes over to cleave the 
linked chromatids (Mankouri et al., 2011). Nucleolytic resolution is triggered by CDK1-
dependent phosphorylation of SLX4, which acts as a platform for the activity of the 
MUS81/EME1 nuclease complex. If all of the above fail and junctions persist, the last attempt 
to resolve these intermediates relies on the GEN1 nuclease. In contrast to MUS81, which is 
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activated in mitosis through phosphorylation, the premature action of GEN1 is limited by 
excluding it from the nucleus until the nuclear envelope breaks down during mitosis (Hustedt 
and Durocher, 2016, West et al., 2015, Chan and West, 2014, Garner et al., 2013). All of 
these nucleases resolve HJs by introducing symmetrical nicks in strands with the same 
polarity, upon which the broken DNA can be simply religated. Again, whether a crossover or 
non crossover product is generated during this reaction depends on the orientation of the 
cleavage (Matos and West, 2014). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 - HR-mediated repair leading to the generation of a double Holliday junction that is 
processed either by the anti-recombinogenic pathway of dissolution or by the nuclease-
dependent pathway of resolution. Modified from Forget and Kowalczykowski (2010).  
The repair of DSBs starts with the resection of the 5′ terminated strand, which results in a 3′ terminated 
ssDNA tail.  Rad51, assisted by several factors such as BRCA1, assembles as nucleoprotein filament onto 
ssDNA. Next, Rad51 locates the homologous region on the homologous chromosome and exchanges DNA 
strands. The synthesis of the missing DNA leads to the formation of two HJs. These structures will be either 
processed through the dissolution pathway by BTR complex (BLM, TOPOIIIα, RMI1 and RMI2) without the 
generation of crossover products, or by the recombinogenic pathway of resolution, that is achieved by 
nucleases and allows the exchange of genetic material between homologous chromosomes. 
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1.4 - Consequences of replication stress in mitosis 
 
If checkpoints fail to block mitotic entry, the presence of non-fully replicated regions or 
unresolved repair intermediates can have severe consequences on chromosome 
segregation (Mankouri et al., 2013). There are a number of sources of problems that can limit 
DNA replication. For instance, HR-mediated repair involves the formation of joint DNA 
molecules at the HJ (Chan and West, 2015). If these structures persist at mitosis, the 
physical association between sister-chromatids would impede their disjunction in anaphase, 
resulting in DNA bridges (Figure 4) (Gelot et al., 2015, Hustedt and Durocher, 2016). Due to 
their toxicity, mitotic cells have several non-redundant pathways in order to process such 
structures and allow chromosome segregation.  
The presence of unreplicated DNA constitutes a potential source of DNA breaks. The 
mechanical tension generated in anaphase can lead to the breakage of the unreplicated 
chromosome, resulting in the uneven segregation of the broken chromosome arms 
(Magdalou et al., 2014). Alternatively, if the tension fails to pull the two chromatids apart both 
chromatids may be pulled towards the same mitotic spindle, leading to aneuploidy (Gelot et 
al., 2015). Moreover, unresolved replication is frequently associated with the generation of 
extra centrosomes in mitosis, which are often functional and can promote multipolar mitosis 
and unbalanced segregation (Magdalou et al., 2014, Gelot et al., 2015). Mis-segregated or 
broken chromosome pieces are thought to be the source of micronuclei. Also, the signal of 
the unresolved DNA damage can be transmitted to the next G1 phase and can be visualized 
as accumulation of the protein 53BP1, known as 53BP1 bodies. Their function is still unclear, 
but it is likely that these structures are necessary to mark and facilitate the repair of these 
lesions, or to block their repair until S phase when HR becomes available (Gelot et al., 2015, 
Hustedt and Durocher, 2016, Lukas et al., 2011).  
In some circumstances cells can bypass mitosis, although having replicated their genome in 
the previous S-phase. Therefore, the cell will start the new cycle with an altered ploidy status, 
carrying double amount of DNA. While polyploid genomes are common in plants and the 
progressive accumulation of polyploid cells is physiological in some tissues, the duplication 
of the genetic material has to be rather considered a pathological event. Changes in the 
genome content are believed to contribute to genomic instability and to provide a route to 
tumorigenesis. Several mechanisms have been identified in promoting polyploidization, 
including cell fusion and a variety of defects that interfere with the cell cycle machinery 
(Storchova and Pellman, 2004). Noteworthy, the presence of unresolvable and/or 
unreplicated chromosomes can also promote mitotic slippage. Hence, replication stress can 
also be a source of alterations in ploidy such as aneuploidy or poliploidy. 
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2 - Physiological outcome of defective DNA damage response 
2.1 - Genomic instability can trigger cancer and ageing  
In response to persistent genomic insults, the DDR can induce apoptosis or cellular 
senescence, a condition of permanent growth arrest that represents a physiological 
mechanism to counteract tumorigenesis (Bartek et al., 2007, Maslov and Vijg, 2009). In 
agreement with this, cancer cells often acquire mutations conferring the ability to disable the 
DDR barrier, thus, allowing to escape apoptosis and senescence. These cells will 
accumulate further mutations and give rise to neoplastic lesions (Campisi, 2003). Although 
cellular senescence was always associated with anti-tumorigenesis, recent findings suggests 
that senescence is a ‘double edge sword’ as it can also drive malignant transformation. 
Senescence cells often secrete degradative enzymes, growth factors and cytokines, which 
may alter the homeostasis of the tissue microenvironment and promote proliferation and 
malignant phenotypes in neighbour cells (Magdalou et al., 2014, Campisi, 2003). Finally, and 
besides its role in cancer, apoptosis and cellular senescence can compromise the 
functionality of a certain tissue and can impair the regenerative potential of stem cells, both 
hallmarks of ageing (Collado et al., 2007). Likewise, the accumulation of senescence within 
tissues is associated with the development of age-related pathologies (Campisi, 2003). 
 
2.2 - Defective DNA repair syndromes 
Deficiencies in DNA repair are a frequent source of hereditary diseases. For their study, 
mouse models have provided a unique tool to investigate on their molecular basis and have 
provided valuable insights into the consequences of genomic instability in vivo. Some of 
these disease models are cancer prone, whereas some defects are associated with a 
premature ageing phenotype. However, in both cases there is an enormous variability of 
clinical signs. Although a clear link between defects and phenotypes has not been provided 
yet, it is very likely that the effect of genomic instability is mostly dependent on the severity of 
the mutation. While severe deficiencies in the DDR pathways are more likely to promote 
senescence and or cell death, and therefore lead to ageing, milder conditions may increase 
the mutation burden and thus predispose to cancer (Finkel et al., 2007).  
 
2.2.1 - Premature ageing syndromes  
Progeroid syndromes support the tight association between the accumulation of DNA 
damage and ageing. In fact, most premature ageing diseases have been linked to defects in 
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DNA repair. One example, which is linked to replication stress, is that of the Seckel 
Syndrome (SS). SS is an autosomal recessive disorder. It has been described for the first 
time in the early sixties by Helmut Seckel (Seckel, 1960) and it is characterized by 
intrauterine growth retardation, severe dwarfism, microcephaly and mental retardation 
(O'Driscoll et al., 2003). In one of its forms, the disease in humans derives from a mutation in 
the ATR gene, which introduces a splicing defect and reduces significantly the amount of 
ATR. Yet a residual level of protein is still sufficient to allow compatibility with life (Murga et 
al., 2009, O'Driscoll et al., 2003). These individuals present impaired ATR activity that plays a 
critical role in sensing replication stress. ATR induces a signalling pathway that leads to cell 
cycle arrest and eventually to the repair of replicative damage. A SS mouse model generated 
in our lab (Murga et al., 2009) recapitulates the phenotypes observed in humans to a large 
extent. Beside dwarfism and developmental defects, these mice died prematurely (within the 
first 6 months), and presented several phenotypes associated with ageing, including hair 
greying and decreased density of hair follicles, thinner epidermis, osteoporosis, accumulation 
of fat in the bone marrow and pancytopenia.  
Perhaps the best example of premature ageing syndromes is the Werner syndrome (WS), 
due to its remarkable similarity to normal ageing (Ciccia and Elledge, 2010). 58 mutations in 
the REQ-like helicase WRN have been identified in patients with WS phenotypes. All these 
mutations result in the expression of a truncated protein and in the loss of the helicase and 
exonuclease activities of WRN (Kudlow et al., 2007, Huang et al., 2006, Friedrich et al., 
2010). Individuals affected by WS develop normally until the first decade of life. Onset of 
symptoms usually occurs in the early 20s, when patients start to display a variety of ageing 
phenotypes such as short stature, bilateral cataracts, early greying and loss of hair, type 2 
diabetes mellitus, osteoporosis and scleroderma-like skin changes (Huang et al., 2006, 
Kudlow et al., 2007). Beside features of accelerating ageing, these individuals are also highly 
predisposed to develop cancer. The median age of death has been reported to occur 
between 47-54 years, usually as a result of malignancies or cardiovascular diseases (Rossi 
et al., 2010, Huang et al., 2006). As in the case of ATR, the role of the WRN helicase has 
been linked to the processing of DNA substrates generated during HR repair and in telomere 
maintenance. In absence of WRN these toxic intermediates and short telomeres accumulate, 
triggering genetic instability, DNA damage response and apoptosis (Kudlow et al., 2007). 
Given that WRN has a critical role in multiple pathways, it is not surprising that WRN 
deficiencies result in such a severe phenotype.  
In regards to mouse models, one of the most studied model for ageing is the ERCC1-
deficient mouse model. ERCC1 forms a specific endonuclease complex by association with 
the protein XPF. The ERCC1/XPF complex catalyses the initial incision step in the 
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Nucleotide Excision repair (NER) pathways after a variety of DNA insults, including UV 
adducts and inter-strand crosslink (ICL) (Gregg et al., 2011). Generation of ERCC1-deficient 
mice was first reported by two independent studies (McWhir et al., 1993, Weeda et al., 
1997). McWhir et al. (1993) targeted exon 5 resulting in the expression of a truncated protein 
lacking of the XPF-interacting domain. The second transgenic strain was generated by 
Weeda et al. (1997) by inserting a neomycin resistant cassette into Ercc1 exon 7, also 
affecting the interaction domain with XPF (Gregg et al., 2011).  Both models suffer from 
severe growth impairment: the knockout mice weight only 20% of control animals as well as 
mice display reduced lifespan, dying prematurely at the age of three weeks. Although the 
hematopoietic system is initially normal, mice become rapidly leukopenic and 
thrombocytopenic and adipose tissue gradually accumulates in the bone marrow (Gregg et 
al., 2011). Interestingly, like many DNA repair pathologies, ERCC1 deficiency affects 
preferentially one specific organ, where ERCC1 is likely to fulfil a more crucial function. This 
phenomenon is normally known as segmental progeria. For instance, major abnormalities in 
liver nuclei emerged by histological examination in ERCC1-deficient mice including an 
accumulation of polyploid and aneuploid hepatocytes (Gregg et al., 2011, McWhir et al., 
1993, Weeda et al., 1997). Such alteration ultimately leads to an impaired liver function as 
demonstrated by the increase of liver enzymes in serum (McWhir et al., 1993). Similar 
abnormalities were also found in other tissues such as skin, spleen and kidneys (Weeda et 
al., 1997). Defects in ERCC1 in humans cause celebro-oculo-facio-skeletal (COFS) 
syndrome, which is characterised by a severe growth retardation, microcephaly, facial 
dysmorphism, kyphosis and psychomotor disability (O'Driscoll et al., 2003). 
 
2.2.2 - Cancer-prone syndromes 
For some defects in DDR genes, there is a very strong association with cancer 
predisposition. For instance, a number of tumour suppressor genes are indeed involved in 
DNA repair and their loss results in severe genomic instability. Again, inherited mutations in 
these gene also leads to severe hereditary disorders.  
The Bloom syndrome (BS) is one of the best-characterised cancer-prone syndromes. The 
disease can be caused by different mutations in the BLM gene, which encodes the RecQ 
helicase BLM (Carrero et al., 2016). Although WRN and BLM helicases belong to the same 
family of proteins, mutations in these genes result in very distinct clinical outcomes. While BS 
affects significantly the lifespan without any evident sign of accelerated ageing, onset of 
ageing-associated features occurs prematurely in individuals affected by WS (de Renty and 
Ellis, 2017). BS patients generally die before the age of 30 due to complications from cancer. 
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It was estimated that affected individuals are 99 times more likely to be diagnosed with 
cancer compared to the general population (de Renty and Ellis, 2017). Interestingly, loss of 
functional BLM can predispose to cancers of different cellular origins and many cancer types 
have been reported to be associated with such mutations (Hickson, 2003). 
High incidence of malignancies in BS patients is a result of the hyper-recombination 
displayed by BLM-deficient cells, which is the distinctive hallmark of this genetic disorder 
(Figure 5). Loss of BLM results in a 10-fold increase in Sister Chromatid Exchange (SCE), 
which derives from the repair of DNA joint molecules (de Renty and Ellis, 2017). The 
helicase BLM is implicated in a recombination free pathway that ensures that replication 
intermediates are processed without crossover (Ira et al., 2003). In cells isolated from BS 
patients these structures are instead processed through the resolution pathway that allows 
the exchange of genetic material between sister-chromatids, leading to a major increase in 
sister chromatin exchange events.  
 
 
Along with the recombination phenotype, BLM deficiency causes a variety of chromosomal 
defects at cellular level, including chromosome breaks, telomere associations, radials, 
lagging chromosomes and anaphases bridges (de Renty and Ellis, 2017, German et al., 
1974).  
Similarly to BS, Fanconi anaemia (FA) is also a genetic condition characterized by genomic 
instability and predisposition to cancer. In this case, the disease is triggered by defects in the 
DNA repair pathway that deals with ICLs, one of the most deleterious insult that can be 
inflicted to DNA. Therefore, FA has been extensively studied as a disease model in order to 
give insights on how repair of ICLs is achieved (Deans and West, 2011). Up to now, 
mutations in 19 genes have been linked to FA and for some patients the genetic defect 
responsible for the disease has not been identified yet (Kottemann and Smogorzewska, 
2013). All these proteins are believed to operate in a common multistep cellular pathway that 
coordinates several repair systems, including HR, nucleotide excision repair (NER) and 
translesion synthesis (TLS)  (Deans and West, 2011).  
Fig. 5 - Hyper-recombination in BLM-
deficient cells (Heyer, 2004). 
Exchange of genetic material between sister-
chromatids in BLM-deficient cells isolated from 
a patient affected by BS. Chromatids are 
labeled with two different dyes in order to 
visualize exchange between sister-chromatids. 
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One of the current models proposes that the ICL lesion is first recognized by FANCM, a DNA 
binding protein with helicase motifs, together with Fanconi anaemia associated protein 24 
(FAAP24) and the histone fold proteins MHF1 and MHF2. Once on chromatin, FANCM acts 
as a platform for the assembly of the FA core complex, which consists of 14 proteins 
(FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, FANCT, FAAP100, 
MHF1, MHF2, FAAP20 and FAAP24). Upon activation, the ubiquitin ligase FANCL, which is 
part of the FA core complex, promotes the mono-ubiquitination of FANCD2-FANCI 
heterodimer (Ceccaldi et al., 2016, Wang, 2008). Ultimately, mono-ubiquitinated FANCD2-
FANCI recruits downstream effectors of the FA pathway, including SLX4 which activates 
structure-specific endonucleases such as ERCC1, ERCC4, MUS81-EME1 and SLX1. The 
nucleolytic incision generates DSBs that are finally repaired by HR (Figure 6) (Ceccaldi et 
al., 2016).  
 
 
 
 
 
At a cellular level, the FA patients accumulate DNA damage at increased rates and cells 
from affected individuals are hypersensitive to ICL agents, such as Mitomycin C (MMC) and 
diepoxybutane (DEB). Upon ICL damage, radial chromosomes and breaks characterize the 
metaphase spreads of FA-deficient cells (Figure 7a) and the quantification of these 
aberrations are commonly used in the clinic to provide a diagnosis of FA (Moldovan and 
D'Andrea, 2009). 
Another striking feature of FA is the bone marrow failure, indicating the crucial role of the FA 
pathway in hematopoietic stem cells expansion and maintenance (Ceccaldi et al., 2016, 
Fig.  6 - Activation of the FA pathway. 
The ICL lesion is sensed by FANCM. Upon activation, FANCM induces the formation of the FA core complex, 
which is composed by 14 FA proteins. The ubiquitin-ligase FANCL, within the FA core complex, mono-
ubiquitinates and activates the FANCD2-FANCI heterodimer. Next, the FANCD2-FANCI heterodimer recruits 
nucleases to excise the lesion. DSBs arised from the nucleolytic cleavage are processed by the HR pathway.  
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Kottemann and Smogorzewska, 2013). The onset of haematological defects occurs within 
the first two decades of life and they include anemia (Figure 7b) and thrombocytopaenia, 
which are frequently proceeded by neutropaenia. The affected individuals often develop 
clonal abnormalities in the bone marrow, which may lead to myelodysplasia or AML 
(D'Andrea and Grompe, 2003). FA patients can develop a variety of cancer types besides 
AML, including gynaecological, head and neck squamous cell carcinoma, oesophageal 
cancer, liver, brain, skin and renal tumours (Michl et al., 2016). Due to hypersensitivity of 
patients cells to ICL-inducing agents, these  compounds are excluded from treatment 
strategies of FA cancer patients (Deans and West, 2011), which severely limits their choices 
for treatment. 
 
 
 
 
 
Although the FA pathway repairs lesions originated from ICL-inducing chemotherapeutic 
agents, FA patients do not usually come in contact with these compounds during their lives. 
It has thus been postulated that the genotoxic threat can instead arise from endogenous 
metabolism. Namely, that the clinical manifestations of the FA syndrome are due to the 
accumulation of endogenous damage that cannot be processed when the FA pathway is 
defective. In support of this hypothesis, sensitivity to formaldehyde and acetaldehyde, which 
are generated in cells as byproducts of our own metabolism, has been shown in cells 
mutated for different FA genes (Rosado et al., 2011). Moreover, inactivation of the FA 
pathway in combination with a deficiency in alcohol dehydrogenase 5 (ADH5), the main 
enzyme in formaldehyde catabolism, results in synthetic lethality in DT40 cells (Rosado et 
al., 2011). A double knockout for FANCD2 and aldehyde dehydrogenase 2 (ALDH2), 
Fig. 7 - Hallmarks of Fanconi anemia.  
a) Presence of radial chromosomes and chromosome breaks in metaphase spread of cells isolated from 
FA patients (Moldovan and D'Andrea, 2009). 
b) Analysis of erythrocytes performed by Guido Fanconi on the first FA patient in 1927. Erythrocytes 
from control (left) and FA patient (right). FA blood sample shows few, large and irregularly shaped 
erythrocytes. Modified from Lobiz and Velleuer (2006). 
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essential for the elimination of toxic acetaldehyde, was also synthetic lethal in mice 
(Langevin et al., 2011, Garaycoechea et al., 2012). All these studies support the contribution 
of the FA pathway in the repair of acetaldehyde and formaldehyde-induced damage, and 
prove that the FA pathway becomes indispensable in absence of enzymes able to catabolise 
these compounds. 
 
2.3 - DNA damage and kidneys disorders 
Finally, and besides cancer and ageing, a connection between DNA damage and kidney 
disorders emerged recently from clinical cases and from transgenic mice work. These 
studies demonstrated that particular types of DNA damage, not yet fully understood, can lead 
to a distinct pathological condition known as Karyomegalic Interstitial Nephritis (KIN). KIN is 
a rare nephronophthisis (NPHP)-related condition characterized by renal tubular 
degeneration that progressively leads to kidney failure. Diagnosis of KIN occurs through 
histological analysis that reveals the striking features of KIN: tubular basement membrane 
degeneration, tubular microcysts and dilation, widespread fibrosis and tubular cell 
karyomegaly (enlarged nuclei) (Figure 8a) (Zhou et al., 2012, Lachaud et al., 2016). The 
enlargement of tubular cell nuclei reflects the ploidy status of these cells. The use of probes 
hybridizing to selected chromosomal regions confirmed the polyploidy content of kidney cells 
in transgenic mice affected by KIN (Thongthip et al., 2016). 
Up to now, only mutations in the FAN1 gene have been reported to induce KIN in humans 
(Zhou et al., 2012). The nuclease FAN1 was first identified through genetic screenings 
designed to identify factors providing resistance to ICL damage (Zhou et al., 2012, 
Smogorzewska et al., 2010). Driven by the clear implication of the nuclease in ICL repair, 
many studies investigated the connection of FAN1 with the FA pathway that is the main route 
to repair ICLs. In fact, FAN1 was shown to interact with FANCD2 and this interaction is 
critical for FAN1 localization at the site of damage (Smogorzewska et al., 2010, MacKay et 
al., 2010). These observations placed FAN1 as a key downstream effector of the FA pathway 
and provided evidence of KIN being a condition triggered by defects in the repair of ICLs. 
Also, FAN1-deficient cells isolated from patients are sensitive to ICLs and display radial 
chromosomes in their metaphases upon damaging conditions, both common hallmarks of FA 
(Zhou et al., 2012) (Figure 8b). 
Despite the phenotype similarity and the collaboration of FAN1 with the FA pathway, 
individuals carrying mutations in FAN1 gene do not suffer from all the clinical signs displayed 
by FA patients, such as cancer predisposition and bone marrow failure. Therefore, FAN1 is 
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not a typical susceptibility gene for FA and might have a distinct role in DNA repair, which 
cannot be restricted to the FA pathway (Lans and Hoeijmakers, 2012). 
 
 
 
 
 
 
Other clinical cases of KIN in humans have been reported without a clear association to a 
specific genetic defect. In many patients, the development of KIN has been explained 
through the contact with the mycotoxin Ochratoxin A (OTA), after the detection of this 
compound in blood and urine (Hassen et al., 2004, Godin et al., 1996). Consistently, OTA 
nephrotoxicity and renal carcinogenesis has been proven in mice and rats (Adler et al., 2009, 
Vettorazzi et al., 2011, Taniai et al., 2014). While the actual mechanism of action of OTA is 
not well understood, however, there is evidence that OTA disrupts renal tubuli by generating 
DNA damage (Cosimi et al., 2009, Mally et al., 2005, Mosesso et al., 2008, Mally, 2012). In 
addition, OTA has been shown to behave as a catalytic inhibitor of Topoisomerase II, 
providing a potential link of the disease to topological stress (Cosimi et al., 2009). To further 
support the link with DNA damage, KIN has been also linked to treatment with cytotoxic 
drugs used in the clinic as chemotherapeutics. For instance, features of KIN have been 
reported in cancer patients treated with busulfan and ifosfamide (McCulloch et al., 2011, 
Mihatsch et al., 1979, Burry, 1974, Godin et al., 1996, Jayasurya et al., 2016). 
Fig. 8 - Mutations in FAN1 induce KIN. Modified from Zhou et al. (2012). 
a) Histopathology from a patient carrying mutations in the FAN1 gene. Widespread fibrosis in blue-grey 
stained by Masson’s Trichrome in the left panel. Karyomegalic cells (white arrow heads) and tubular 
dilation (asterisks) in the central and right panel. 
b) Presence of radial chromosomes (red arrows) and chromosome breaks (black arrows) upon MMC 
treatment in metaphase spreads of cells isolated from non-FA, FA patients and two individuals carrying 
mutations in FAN1 gene. 
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3 - Structural maintenance of Chromosomes  
The accurate transmission of the genetic information from mother to daughter cells is of 
crucial importance for the survival of an organism. Therefore, the maintenance of genomic 
integrity is highly controlled. One of the pathways that ensures the correct chromosomal 
architecture and organization involves the Structural Maintenance of Chromosomes (SMC) 
family.  
Each SMC protein consists of 1000-1500 aminoacids and contains globular N- and C-
terminal ATPase domains (Walker A and B motifs) linked by two long α-helixes folded 
against each other at a central globular hinge domain (Jacome et al., 2015, Jeppsson et al., 
2014, Murray and Carr, 2008, Losada and Hirano, 2005) (Figure 9a). While a single SMC 
protein is present in bacteria, six have been identified in eukaryotes. All eukaryotic SMC 
complexes are organized into SMC protein heterodimers, all linked through the hinge region, 
whereas the non-SMC subunits hold the ATPase domains together (Murray and Carr, 2008, 
Verver et al., 2016). In eukaryotes, these six SMC proteins are organized into three 
independent heterodimeric complexes named SMC1/3 (cohesin), SMC2/4 (condensin), and 
SMC5/6 complex (Figure 9b).  
The cohesin complex is essential to maintain the cohesion of sister chromatids. Cohesins 
generate a counterforce to the mitotic spindle and facilitate chromosome alignment. 
Condensins, on the other hand, promote the compaction and the disentanglement of sister 
chromatids. While the role of cohesins and condensins in regulating chromosome 
architecture is well characterized, the true function of the SMC5/6 complex function is still not 
fully understood (Jeppsson et al., 2014).  
Although prokaryotic SMC proteins share higher sequence and structural similarity with 
cohesins and condensins, SMC5/6 appears more closely related to the prokaryotic complex 
in terms of phenotype similarity when these proteins are mutated. This observation suggests 
that the SMC5/6 complex have diverged faster than cohesins and condensins from their last 
common ancestor. It has been recently proposed that the SMC complexes derive from a 
SMC5/6-like common ancestor, from which a cohesin-condensin-like common ancestor 
originated, and later cohesins and condensins evolved through a series of gene duplication 
events  (Palecek and Gruber, 2015).  
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3.1 - Architecture of the SMC5/6 complex  
The SMC5/6 complex is composed of two SMC elements, SMC5 and SMC6 (the SMC5/6 
heterodimer), and 6 non-SMC elements named Nse1-6 in yeasts (NSMCE1-6 in higher 
organisms). A second level of organization has been described in yeasts where there is 
evidence of the subunits being organized into three subcomplexes. One of these 
subcomplexes is formed by the two SMC proteins and Nse2 bound to the coiled-coil domain 
of Smc5 (Duan et al., 2009). Interestingly, a Smc5-Nse2 dimer lacking of Smc6 might exist in 
Fig. 9 - Architecture of SMC complexes in yeasts (Jeppsson et al., 2014). 
a) Structure of unfolded SMC proteins. Each SMC protein has a central globular hinge domain. The hinge 
domain is flanked by coiled-coil regions, both of which end with a globular domain (Walker A or a 
Walker B motifs). The coiled-coil domains associate through antiparallel interaction, bringing the Walker 
A and B motifs together to form the ATPase domain of the SMC protein. 
b) Members of SMC family (cohesins, condensins and SMC5/6 complex) in eukaryotes and composition. 
In each complex, two SMC proteins interact through the hinge domain and assume a V-shape structure. 
These subunits are Smc1 and Smc3 for the cohesin complex, Smc2 and Smc4 for the condensin and 
Smc5 and Smc6 form the SMC-5/6 complex. Complex-specific non-SMC subunits further associate to the 
SMC heterodimers. Kleisin proteins held together the globular head domains of the SMC proteins and 
allow the heterodimer to adopt a ring-like structures. Non-SMC members of the cohesin complex are 
Pds5, Wpl1 and the kleisin subunit Scc1 and Scc3. In yeast, Brn1 bridges the Smc2 and Smc4 head 
domains and Ycs4 and Ycg1 further associate to the complex. Beside the SMC heterodimer in the SMC-
5/6 complex, 6 additional elements are part of the complex: Nse1, Nse2 (Mms21), Nse3, the kleisin 
subunit Nse4, Nse5 and Nse6. 
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mitosis outside the complex (Stephan et al., 2011). Nse1, Nse3 and Nse4 associate together 
to the globular heads of the SMC proteins. Nse5 and Nse6 form a dimer that in budding 
yeasts interacts with the hinges domains of Smc5 and Smc6 and in fission yeast associates 
with the globular heads (Stephan et al., 2011, Kegel and Sjögren, 2010).  
Beside the ATPase activity of the SMC proteins, small ubiquitin modifier (SUMO) ligase and 
ubiquitin ligase activities have been described. Nse1 and Nse2 contain RING fingers 
domains, suggesting the ability of these proteins to conjugate ubiquitin or ubiquin-like 
proteins to protein targets. Nse1 carries a RING finger domain enabling ubiquitin 
modification. Nse2 contains a catalytic SP-like ring and belongs to Siz1/PIAS (SP) family of 
E3 SUMO-ligases (Stephan et al., 2011). Sumoylation induced by Nse2 does not result in 
mono- o di-sumoylation but poly-sumoylation and/or multiple sumoylation attaching sites. 
Nse2 targets include components of the SMC5/6 complex, Nse2 itself, shelterin subunits and 
Ku70 (Kliszczak et al., 2012). Although, most of SUMO ligases contain a SAP sequence 
required for DNA binding, Nse2 does not have this motif and bind DNA through its interaction 
with the SMC5/6 complex (Duan et al., 2009).  
 
3.2 - The enigmatic role of the SMC5/6 complex in chromosome maintenance 
Since, besides the ATPase activity of the globular domains of SMC5 and SMC6, the ubiquitin 
ligase Nse1 and the SUMO-ligase Nse2 are the only known enzymatic activities within the 
complex, it was assumed that the mechanisms to preserve chromosomes structure by 
SMC5/6 complex occurred exclusively through their activities (Fernandez-Capetillo, 2016). 
However, the abrogation of Nse1 or Nse2 enzymatic activities in mutant yeasts does not 
affect viability, whereas the deletion of these proteins is lethal (Andrews et al., 2005, 
Pebernard et al., 2008a). These findings suggest that the role of these enzymatic activities 
could be rather a fine tuning one, whereas the role of the actual SMC5/6 in structural integrity 
would be what makes it essential. Accordingly, all the components of the complex are 
required for viability in Saccharomyces cerevisiae and all except Nse5 and Nse6 are 
essential in Schizosaccaromyces pombe (Stephan et al., 2011). 
The SMC5/6 complex shows a dynamic pattern of localization throughout the cell cycle. For 
instance the complex binds origins of replication in S-phase, while associate to centromeres 
and other chromosomal regions in G2-M (Lindroos et al., 2006, Menolfi et al., 2015, Bustard 
et al., 2012). In a recent study in yeast, SMC5/6 functions were restricted to either S-phase 
or G2-M, by using cell cycle-regulated alleles in order to separate the potential functions of 
the complex and to evaluate the outcome of their loss (Bustard et al., 2012, Menolfi et al., 
2015). While restricting the function of SMC5/6 to G2-M had no effect on viability, its absence 
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in G2-M was lethal. Therefore, the essential functions of the SMC5/6 complex are due to its 
roles in G2-M (Menolfi et al., 2015). Moreover, expression of the complex in mitosis is 
sufficient to enable the growth of SMC5/6 complex deficient yeast strains, suggesting that its 
role is similar to the one of the BLM helicase and linked to the dissolution of HJs (Bermúdez-
López et al., 2010).  
The first evidence of the SMC5/6 complex being involved in genome maintenance comes 
from the identification of rad18 (Smc6) and mms21 (Nse2) mutants as being sensitive to the 
alkylating agent MMS (Prakash and Prakash, 1977, Nasim and Smith, 1975). Mutations 
inactivating Nse2 SUMO ligase activity in yeast also sensitize cells to a variety of genotoxic 
agents, including hydroxyurea (HU), IR, UV and MMS, although to a much lower extent to 
the sensitivity observed in null alleles (Andrews et al., 2005, McDonald et al., 2003, Stephan 
et al., 2011).  
Epistatic relationships between the SMC5/6 complex and HR repair factors supports the 
implication of the complex in HR repair. For instance, IR sensitivity of Smc6 mutants in yeast 
could be rescued by deletion of RAD51, one of the main actors of HR (Stephan et al., 2011, 
Lehmann et al., 1995). Interestingly, the absence of SMC components does not affect early 
events of HR repair, such as RAD51 recruitment (Stephan et al., 2011). These observations 
place the SMC5/6 complex in the latest steps of HR after RAD51-mediated strand invasion 
and D-loop formation. On the other hand, it has been argued that the function of the complex 
may go beyond HR and DNA repair, since every member of the complex is essential for life 
in yeast, whereas HR is not. Moreover, not only HR can still occur in absence of functional 
SMC5/6, in fact the outcome of repair is dramatically affected with increased SCE levels and 
recombination (Stephan et al., 2011). As such, Nse2 mutant yeasts, but also chicken SMC5 
knockout cells and hypomorphic SMC6 mice, are all characterized by increased rate of 
recombination (Prakash and Prakash, 1977, Kliszczak et al., 2012, Ju et al., 2013).  
Whereas the role of SMC5/6 in HR is unclear, a widely accepted role for the SMC5/6 
complex consists in the processing of sister-chromatids linkages, as exemplified by the 
accumulation of cruciform structures in mutant yeasts (Ampatzidou et al., 2006, Branzei et 
al., 2006, Bermúdez-López et al., 2010, Yong-Gonzales et al., 2012, Sollier et al., 2009). 
Some of these structures represent the products of HR repair that remain entangled. In 
support of this, RAD51 deletion prevents the accumulation of these linked molecules in 
SMC5/6 mutants and alleviate overall sickness of the mutants (Fernandez-Capetillo, 2016, 
Torres-Rosell et al., 2005, Yong-Gonzales et al., 2012). This phenomenon is remarkably 
similar to that observed in BLM-deficient cells, where joint DNA molecule dissolution is 
impaired. Hence, in the absence of a functional SMC5/6 complex, the dissolution pathway 
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that is in charge of processing these repair intermediates without cross-over appears 
abrogated and joint DNA molecules are instead repaired by the recombination-prone 
pathway of resolution, explaining the observed increase in SCE events.  
In regards to the nature of these joint molecules, the SMC5/6 complex operates preferentially 
at repetitive sequences that are difficult to replicate and prone to fork stalling and collapse. 
Indeed, Smc5/6 localizes at natural replication pausing sites, centromeres and telomeres 
(Ampatzidou et al., 2006, Lindroos et al., 2006, Menolfi et al., 2015, Pebernard et al., 2008a, 
Pebernard et al., 2008b). Replication problems occurring at these loci are in fact repaired by 
HR through the generation of recombination intermediates. Hence, in the absence of Smc6 
joint DNA molecules accumulate at ribosomal arrays (rDNA repeats) regions, the biggest 
repeat in yeast, and murine NSMCE2 accumulates at pericentromeric DNA, the biggest 
mammalian repeat (Torres-Rosell et al., 2005, Lindroos et al., 2006, Fernandez-Capetillo, 
2016). Besides its involvement in joint DNA molecule dissolution, or perhaps linked to it, 
several works have shown that the role of SMC5/6 is linked to chromosomal topology, and 
synthetic lethal interactions of Smc5/6 mutants with Topoisomerase mutants have been 
reported (Takahashi et al., 2008, Outwin et al., 2009). Related to this role, the analysis of 
SMC6 localization revealed a distinct role of the complex in the maintenance of long 
chromosomes (Kegel et al., 2011, Lindroos et al., 2006), which was also related to 
Topoisomerase activity.  
Altogether, although the initial role of SMC5/6 was placed in HR, it is becoming more and 
more evident that the complex holds essential HR-independent functions that are related to 
chromosome topology and segregation, which are yet to be fully understood. 
 
3.3 - Mutations of SMC5/6 complex in humans 
So far, two genetic disorders have been described to arise from mutations in components of 
the SMC5/6 complex (Payne et al., 2014, van der Crabben et al., 2016). Since complete 
depletion of any components is lethal, these mutations do not completely abrogate the 
expression of the protein and preserve some functions of the SMC5/6 complex that are 
compatible with life. 
First, two female patients displaying a variety of pathological features, including severe 
primordial dwarfism, facial dysmorphism, extremely insulin resistant diabetes, fatty liver, 
hypertriglyceridemia and primary gonadal failure, were found to carry distinct heterozygous 
frame-shift mutations in the SUMO ligase NSMCE2.  One of these mutations occurs between 
the N-terminal and the SP-RING domain and introduces 18 unstructured amino acids. The 
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other results in the removal of 14 C-terminal amino acids of the protein. In both cases, the 
mutations destabilize the protein levels of NSMCE2, resulting in lower protein expression.  
Due to certain similarities, one of the patients was initially examined for potential diagnosis of 
Fanconi Anaemia or Bloom syndrome, but the diagnostic tests for such conditions were 
negative. However, the karyotype analysis showed a moderate number of chromosomal 
breaks. Furthermore, cells isolated from the patients presented increased frequency of 
micronuclei and bridges formation after hydroxyurea (HU)-induced replication fork stalling 
(Payne et al., 2014). Due to the low number of patients and the absence of long-term 
evaluation, the full outcome of this disease is yet to be known. 
Besides NSMCE2 mutations, two missense mutations in NSMCE3 were also found in 4 
patients. These mutations lead to a very different clinical outcome characterized by severe 
pulmonary disease, immune deficiency and increased infection susceptibility. In vitro 
investigations indicate that one of the mutations leads to a C-terminal truncated NSMCE3, 
whereas the other variant shows a reduced interaction with NSMCE4 and SMC6. The 
NSMCE3 mutations disrupt its interaction within the SMC5/6 complex leading to a more 
severe destabilization of the complex compared to the one observed in cells isolated from 
individuals carrying NSMCE2 mutations. In this case, lymphocytes of affected individuals 
showed chromosome rearrangements, breakages and micronuclei and their fibroblasts 
showed sensitivity to different DNA-damaging agents (van der Crabben et al., 2016). The 
increased severity of the mutation is likely responsible for the discrepant phenotypes that are 
observed in both diseases. 
In summary, while initially associated to HR, the true function of the SMC5/6 complex 
remains to be truly understood. The analysis of the phenotypes in mouse models and human 
patients often helps to get a deeper understanding of the physiological role of a given protein 
or complex. Here, I report my research using mouse models of NSMCE2, which led us to 
discover a systemic role of SMC5/6 in chromosome segregation, but also a distinct role for 
NSMCE2, independent of its SUMO ligase activity, in kidney function; and which supports 
that the main role of SMC5/6 is linked to Topoisomerase activity. 
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Objectives 
 
 To analyze the recruitment of NSMCE2 to sites of DNA damage and inter-strand 
crosslinks. 
 To determine the role of NSMCE2 in DNA replication and chromosome segregation. 
 To investigate the consequences of Nsmce2 deletion in adult mice. 
 To characterize the impact of NSMCE2 deficiency specifically in the kidneys. 
 To explore the role of NSMCE2 in the cellular response to topological stress. 
 To determine the functional redundancy of NSMCE2 and FAN1 in response to 
topoisomerase inhibition. 
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Materials and Methods 
 
1 - Mouse work 
1.1 - Maintenance of mice lines and genotyping 
Mice used for this study were kept under standard conditions at the pathogen-free facility of 
the Spanish National Cancer Research (CNIO). All mouse work was performed in 
accordance with the Guidelines for Humane Endpoints for Animals Used in Biomedical 
Research, and under the supervision of the Ethics Committee for Animal Research of the 
“Instituto de Salud Carlos III”. 
In order to genotype the animals, DNA was isolated from small pieces of the animal tail and 
digested for 16 hours  at 55°C with 100 mM NaCl, 50 mM Tris-HCl pH 8, 5 mM EDTA, 1% 
sodium dodecyl sulfate solution (SDS, Sigma) and 400 μg/ml proteinase K (Roche). After 
treating the cellular lysate with saturated 6M NaCl solution, DNA was precipitated with 
isopropanol, washed with 70% ethanol and resuspended in distilled water.  
GoTaq® DNA Polymerase (Promega) was used for genotyping and PCR was carried out 
according to manufacturer’s instruction. Genotyping PCRs were performed in a reaction mix 
composed of 0.2 mM of each dNTP, 1.5 mM MgCl2, 1X green GoTaq® reaction buffer, 1.25 
U GoTaq® DNA polymerase, 0.5 μM of each oligonucleotide, 100 ng of genomic DNA and 
nuclease free water up to 20 μl. 
 
The following primers were used to genotype the Nsmce2lox allele: 
Forward: ATTAGAAAATAATGATCCTAGGAAACATTAATTCTGCAACTCGTTGTT 
Reverse: TAAATACTCATGCCTTTCTTACCCCGTCTTTCT 
A band of 150 bp for the wild-type Nsmce2 allele and a band of 250 bp for the Nsmce2lox 
allele are expected. 
 
The following primers were used to genotype the Nsmce2KI allele: 
Forward: GGTGGGACTGGAGTATTGGA 
Reverse 1: TATGTGCGTTGAGTGTGCAA 
Reverse 2: CAGAAAGCGAAGGAGCAAAG 
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A band of 480 bp for the wild-type Nsmce2 allele and a band of 560 bp for the Nsmce2KI 
allele are expected. 
 
In order to genotype the presence of the UQ.CreERT2 recombinase the following primers were 
used: 
Forward: CGATGCAACGAGTGATGAGGTTC 
Reverse: GCACGTTCACCGGCATCAAC 
A band of 350 bp is expected when the UQ.CreERT2 recombinase allele is present. 
 
In order to genotype the CD19-Cre recombinase allele the following primers were used: 
Forward: AGGGAGGCAATGTTGTGCT 
Reverse 1: GTTCGAACGCTAGAGCCTGTTT 
Reverse 2: TGCCAGACCAAAGAACTTCCTC 
A band of 600 bp for the wild-type allele and a band of 350 bp for the CD19-CreKI allele are 
expected. 
 
For Nsmce2 deletion in UQ.CreERT2 mice, animals were fed with a diet containing 400 mg of 
4-Hydroxytamoxifen (4-OHT) per kg (Harlan Tekland, Madison, USA), starting at weaning. 
 
1.2 - Blood test 
Blood was collected from mice either from the orbital sinus (peri-orbital bleeding) with 
anaesthetized animal or by cardiac puncture after the animals were sacrificed. Blood serum 
was obtained by centrifugation and the levels of renal markers were evaluated by using the 
ABX Pentra 400 apparatus. To this end, quantitative in vitro determination of urea (Urea CP 
ABX Pentra – Horiba), creatinine (ABX Pentra Enzymatic Creatinine CP-Horiba) and albumin 
(ABX Pentra Albumin CP – Horiba) was carried out. 
 
1.3 - Immunohistochemistry  
Tissue samples were embedded in formalin and processed at CNIO’s Pathology Unit. 2.5 µm 
tissue sections were treated with citrate for antigen recovery and processed for p-Ser139 
H2Ax (05-636 Millipore) staining following standard procedures. To evaluate kidney 
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architecture tissue sections were stained with Hematoxilin and Eosin. Levels of fibrosis were 
evaluated by Masson’s Trichrome staining. Kidneys sections were digitalised by using the 
MIRAX system (Zeiss) and the images were captured through the ZEN 2 lite software 
(Zeiss). In order to analyse the renal nuclear area, several images for each renal 
compartments were captured and analysed by the imageJ software. 
 
 
2 - Cellular biology 
2.1 - Cell culture 
Unless otherwise specified, all cell lines were cultured in DMEM media (4.5 g/L Glucose; L-
Glutamine; Lonza, Switzerland) with 10%-15% of inactivated fetal bovine serum (FBS) 
(South American Origin, Lonza) and a mix of penicillin and streptomycin (Gibco, Invitrogen, 
Life Technologies, Carlsbad, CA). Cells were kept in incubators at 37°C and 5% C02, except 
for mouse embryonic fibroblasts (MEFs), that were maintained in hypoxia incubators at 37°C, 
5% C02 and 5% O2. 
Deletion of Nmsce2 in UQ. CreERT2 Nsmce2lox/lox was induced by adding 1 µM 4-
Hydroxytamoxifen (4-OHT, Sigma) to the culture media for at least 48h before the 
corresponding assay. 
Methyl methanesulfonate (MMS, Sigma), Mitomycin C (MMC, Sigma), ICRF-193 (Sigma) 
and Etoposide (Sigma) were used to induce distinct types of DNA damage. 10 Gy IR 
treatment was carried out to induce damage and cells were left to recover for one hour 
before proceeding to the corresponding assay. 
 
2.2 - Isolation of MEFs 
Mice were selected in order to obtain pups with the genotype of interest. At 13.5 days of 
gestation, the female was sacrificed and the embryos were isolated from the mother in sterile 
conditions. The fetal liver was then removed and a piece of head was also isolated for 
genotyping analysis. The rest of the embryo was chopped with a sterile blade and incubated 
for 10 minutes with 1 ml trypsin-0,25% EDTA (Gibco). In order to dissolve the aggregates, 
the solution was mixed vigorously and the trypsin was neutralized by adding 9 ml DMEM 
media (Gibco) supplemented with 15% inactivated fetal bovine serum (FBS) and 1% 
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penicillin/streptomycin (Gibco, Invitrogen, Life Technologies, Carlsbad, CA). Isolated MEFs 
were then transferred to a 100 mm2 petri dish and kept in hypoxia incubators (5% O2).  
 
2.3 - Isolation of splenic B-lymphocytes 
In order to isolate B-lymphocytes from mice spleen, a spleenectomy was carried out. 
Spleens were squeezed onto a 40 µm filter with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4) with 1% bovine serum albumin (BSA Fraction V, Roche) and 
collected into a 15 ml falcon tube. Red blood cells were lysed with a hypotonic buffer solution 
(ACK Lysing Buffer, Lonza). After 5 minutes incubation, the buffer was inactivated by adding 
10 ml of RPMI media (Euroclone). Cells were washed twice with 1X PBS/1% BSA and then 
passed through a 40 µm filter to remove aggregates. Cells were centrifuged again and 
resuspended in 920 µl 1X PBS/1%BSA and 80 µl of anti-CD43 antibody conjugated 
magnetic beads (Miltenyi Biotech, Germany). After 15 minutes incubation at 4°C, cells were 
washed again and resuspended in 1 ml PBS/1%BSA. The solution was transferred into a 
separating column (MS column, Miltenyi) previously equilibrated with 1 ml PBS/1%BSA and 
standing in a magnetic scaffold (OctoMACS separator, Miltenyi). B-lymphocytes were not 
retained by the magnetic field of the column and were collected into a tube. 
1x106 primary B-lymphocytes per ml were finally seeded with RPMI supplemented with 10% 
FBS,  1% penicillin/streptomycin (Gibco, Invitrogen), 2 mM glutamine (Gibco, Invitrogen), 
non-essential aminoacids (Lonza), sodium pyruvate (Gibco, Invitrogen), 50 mM b-
mercaptoetanol (Gibco, Invitrogen) and 10 mM HEPES (Lonza) and 25 µg/ml LPS (Sigma-
Aldrich, St. Louis, MO) was added to induce proliferation. 
 
2.4 - Transient expression of proteins 
Cells were seeded in P24-well plates in order to reach 90-95% confluence at the time of 
transfection. In order to evaluate the potential colocalization between FAN1 and NSMCE2, 
GFP-FAN1 was overexpressed transiently in 3T3 cells. To this end, 3T3 cells were 
transfected with the plasmid pcDNA5 FRT/TO.GFP.Puro.DU FAN1 kindly provided by Dr. 
John Rouse. For each well, 0.5 µg of the plasmid was mixed with 100 µl Optimem® Medium 
(Life Technologies). After a 5 minutes incubation, the mix was combined with 100 µl 
Optimem® Medium and 1 µl LipofectamineTM 2000 (Life Technologies) previously mixed. The 
solution was further incubated for 20 minutes to allow the DNA-LipofectamineTM 2000 
complexes to form. The solution was finally added to the cells by gentle mixing.  
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2.5 - Production of viral particles and stable expression of transgenes 
In order to produce virus particles, 293T cells were transfected with the appropriate viral 
packaging plasmid and with the plasmid containing the desired protein. The media was 
changed 12 h after the transfection and the virus was collected 24 hours later. Before using 
the viral supernatant for the infection, the media was filtered through a 0.45 µm filter. The 
virus was added to cells seeded in 6-well plates and spun at 1850xg for one hour. Then, the 
media was changed and antibiotic selection was carried out after 48h from the infection. 
MEFs were immortalised by the expression of the T121 antigen that was stably integrated by 
using a retroviral system. To this end, pBabe-puro-T121 and pCL-Eco, kindly provided by Dr. 
Manuel Serrano, were transfected in 293T to produce virus particles as previously described.  
 
2.6 - Generation Fan1 knockout cells with CRISPR-Cas9 technology 
Fan1 knockout MEFs were generated by using the CRISPR-Cas9 technology. Three 
different sgRNAs targeting the first exon of the murine Fan1 allele were cloned into the 
lentiviral vector LentiCRISPv2 (Addgene #52961). The following oligos were used: 
 
sgRNA-Fan1-1 
CACCGACTCATCAAGGTGCCGAATG 
AAACCATTCGGCACCTTGATGAGTC 
 
 sgRNA-Fan1-2 
CACCGCGTTCAAGTAGAGCCTGCTC 
AAACGAGCAGGCTCTACTTGAACGC 
 
sgRNA-Fan1-3 
CACCGCTGGTAGATAAGCTTCTACG 
AAACCGTAGAAGCTTATCTACCAGC 
 
Individual lentiviral vectors were co-transfected with 3rd generation packaging vectors 
(pMDL, Rev and VSVg) in 293T cells using Lipofectamine 2000 (Invitrogen) in order to 
generate viral supernatants as described by Ruiz et al. (2011). MEFs were finally infected by 
using a mixture of the three viral supernatants. 
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2.7 - Immunofluorescence and high-throughput microscopy (HTM) 
For high-content screening cells were cultured in μCLEAR bottom 96‐well plates (Greiner 
Bio-One) and treated according to the experimental protocol. Cells were fixed with 4% 
paraformaldehyde (EMS)/PBS at room temperature for 10 minutes and permeabilized with 
0.1% sodium citrate/0.1%Triton X-100 (Sigma)/PBS for 15 minutes. After washing three 
times with 0.25% BSA/0.1% Tween20 (Sigma)/PBS, cells were incubated in blocking solution 
(2.5% BSA, 0.1% Tween20/PBS) for 30 minutes. The corresponding primary antibody diluted 
in blocking solution was incubated over-night at 4°C. After washing 3 times, the secondary 
antibody conjugated to fluorophore was added for 1 hour at room temperature and nuclei 
were stained with DAPI.  
Staining with certain antibodies required a pre-extraction step to prevent the cytoplasm to 
mask nuclear signal. Indeed, cells were treated 3-5 minutes with CSKI pre-extraction solution 
(10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA and 0.5% 
Triton X-100) and, after washing 5 times with 0.25% BSA, 0.1% Tween20 in PBS, cells were 
fixed with mSTF buffer (150 mM 2-bromo-2-nitro-1,3,-propanediol, 108 mM diazolidinyl urea, 
10 mM Na citrate, 50 mM EDTA pH 5.7) for 30 minutes. The preparation was then 
permeabilised with 100 mM Tris-HCl pH 7.4, 50 mM EDTA pH 8 and 0.5% Triton X-100. 
Blocking and immunostaining were performed as previously described. 
Images were automatically acquired by an Opera High-Content Screening System (Perkin 
Elmer). A 40 x magnification lens was used and pictures were taken at non-saturating 
conditions. Images were segmented using the DAPI staining to generate masks matching 
cell nuclei. The number of foci and the intensity average signal of the desired protein within 
the nuclei area were calculated. Data were represented with the use of the Prism software 
(GraphPad Software). 
To evaluate protein colocalization, cells were seeded on a glass coverslip treated with 
gelatin, in a P24 well plate. Cell preparation and immunostaining was performed as 
described. z-stack images were acquired by using a confocal microscope and colocalization 
was evaluated at each layer.  
 
2.8 - Laser irradiation induced damage 
Analysis of proteins recruitment to laser-induced damage was carried out at the microscopy 
facility of the MRC Protein Phosphorylation Unit in Dundee during a short visit for training 
purposes in the lab of Dr. John Rouse.  
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Cells seeded in 35-mm glass-bottomed dishes were incubated for one hour with 50 µM 
trimethyl-psoralen (TMP Sigma-Aldrich) or 50 µM angelicin (Sigma) to induce respectively 
laser stripes of inter- and intra-strand crosslink after UV-A irradiation.  
Before proceeding to the UV-A irradiation step, the culture media was replaced with a 
colourless media (Leibovitz’s, Gibco), to minimize laser diffraction. A 355-nm UV-A laser 
attached to a PALM microscope (Zeiss) was used to irradiate a track along cell nuclei as 
previously described (Lachaud et al., 2014). The power of the laser (percentage of intensity) 
was set to 20% to generate ICLs, and the areas were struck at low speed. 30 minutes after 
the UV-A irradiation, cells were then pre-extracted with 0.5% Triton X-100 in PBS and fixed 
with 4% paraformaldehyde. Immunostaining was performed as described and γH2Ax was 
used as a positive control of recruitment. 
 
2.9 - Chromosomes spread preparation 
Colcemide was added at 0.1 μg/ml during the last 2-5 hours of cell culture.  Cells were then 
collected, washed and resuspended in hypotonic buffer (0.075 M potassium chloride) at 
37°C. After 15 minutes incubation, cells were centrifuged and the cell pellet was gently 
resuspended in methanol: glacial acetic acid (3:1) fixative solution and incubated for 20 
minutes. Cells were then washed with fixative and a few drops were released onto an alcohol 
cleaned slide. Slides were finally stained with Giemsa solution and let the slide dry. 
For SCE analyses, cells were cultured in the presence of BrdU (Sigma) at a final 
concentration of 10 μM and then allowed to replicate their DNA once for 24 hours. 
Metaphases were prepared using the standard procedure described above. Metaphase 
spreads were subsequently treated with UV (355 nm) and Hoechst to counterstain nascent 
DNA strands. 
 
2.10 - Chromosome Orientation Fluorescence In Situ Hybridization (CO-FISH) 
CO-FISH was performed according to the procedure published by Gonzalo et al. (2006). 
Cells were cultured for 16 hours in the presence of 5’-bromo-2’-deoxyuridine (BrdU; Sigma, 
St Louis, MO) at a final concentration of 10 μM. Colcemid was then added at a concentration 
of 0.1 μg/ml for the last hour of incubation. Cells were recovered and metaphase spreads 
were prepared as previously described.  
In order to degrade the newly synthetized DNA strand the slides were treated with 0.5 mg/ml 
RNase A, followed by staining with 0.5 μg/ml Hoechst 33258 (Sigma) in 2x SSC. DNA was 
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then exposed to UV light (365 nm), digested first with 3U/μl exonuclease (Promega) and later 
with 1mg/ml pepsin (Sigma).  
A first probe (TTAGGG) labelled with Cy3 and a second probe (CCCTAA) labelled with 
Rhodamine green (Applied Biosystems, Bedford, MA) were used. Metaphase spreads were 
captured on a Leitz Leica DMRB fluorescence microscope. 
 
2.11 - DNA fiber assay 
Cells were pulse‐labelled with 50 μM CldU for 20 minutes, followed by 250 μM IdU for other 
20 minutes. Labelled cells were collected, and DNA fibers were spread in buffer containing 
0.5% SDS, 200 mM Tris pH 7.4, and 50 mM EDTA. DNA was fixed with freshly made 3:1 
methanol:acetic acid for 2 minutes and slides were treated with 2.5 M HCl for 30 minutes. 
To visualize labelled tracks, fibers were blocked with 1% BSA, 0.1% Triton X-100 in PBS and 
incubated with primary antibodies (for CldU, rat anti‐BrdU; for IdU, mouse anti‐BrdU) Mouse 
anti‐ssDNA antibody was used to assess the integrity of the fibers. Slides were finally 
developed with Alexa-conjugated secondary antibodies. Slides were examined with a Leica 
DM6000 B microscope, as described previously (Mourón et al., 2013). The conversion factor 
used was 1 μm = 2.59 kb (Jackson and Pombo, 1998). In each assay, 200–300 tracks were 
measured to estimate fork rate and 300–500 tracks were analyzed to estimate the frequency 
of origin firing. 
 
2.12 - Flow cytometry analysis 
2.12.1 - Cell cycle analysis  
Cell cycle profiles were analysed by staining B-cells and MEFs with Hoechst staining or 
propidium iodide (PI) staining. For Hoechst staining, one million cells were washed and 
resuspended in pre-warmed culture medium supplemented with 1 μg/ml Hoechst 33342 
(Sigma). The mix was then incubated at 37°C for 30 minutes.  
The samples were otherwise fixed with 70% ethanol over-night and resuspended in PBS 
containing 10 µg/ml propidium iodide (PI, Sigma) and 0.5 mg/ml RNaseA. 
Analytic flow profiles of DNA content were recorded on BD FACSCanto II cytometer. A 
minimum of 10,000 events were counted. Data was analyzed with Flowjo software (XY). 
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2.12.2 - Viability assay by DAPI exclusion  
To assess the sensitivity to ICRF-193, B-cells were stained with DAPI, exploiting the ability of 
the dye to stain exclusively dead cells. Cells were washed and resuspended in 0.2 mg/ml 
DAPI in PBS. Fluorescence data was acquired by BD FACSCanto II cytometer and data was 
analysed by Flowjo software (XY). 
 
2.13 - Clonogenic assays 
The ability to form colonies was assessed in immortalised Nsmce2 conditional knockout 
MEFs. 1000 cells were plated in P6-well plates without and in presence of 4-OHT and the 
media was replaced every 2 days. Cells were kept in culture for 10 days and colonies were 
stained with 0.33% methylene blue (Sigma) in methanol. 
 
2.14 - CellTiter-Glo® Luminescent Cell Viability Assay  
Defects in cell proliferation and drugs sensitivity were assessed by using the CellTiter-Glo® 
Luminescent Cell Viability Assay (Promega). Nsmce2 conditional knockout MEFs were 
seeded in μCLEAR bottom 96‐well plates (Greiner Bio-One) and Nsmce2 deletion was 
induced by treatment with 4-OHT for 48 hours. Cells were then exposed to a range of ICRF-
193 concentration for 48 hours. Chemoluminescence was monitored by the Victor Multiwell 
reader plate (PerkinElmer) 20 minutes after the incubation with the CellTiter-Glo® reagent.  
 
 
3 - Molecular biology and biochemistry 
3.1 - Antibodies 
The following primary antibodies were used: TOPOII (Topogen TG2011-1), NSMCE2 
generated in house, FAN1 (kindly provided by Dr. John Rouse), a-Tubulin (Sigma T-9026), 
H2A (Cell Signaling 3636), γH2AX (Upstate Biotechnology, 05‐636), SMC5 (Biothyl, 
A300‐236A) and SMC5 (kindly provided by Prof. Alan Lehman), H3S10P (Millipore 05-806) 
and H3K93m (Millipore 07-442). 
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3.2 - In house antibody production 
Due to the lack of reagents to study NSMCE2 in mammals, we have generated in house 
antibodies against the murine NSMCE2 protein.  
The cDNA of murine Nsmce2 was cloned into pET-45b (Novagen 71327), which allows the 
expression of the desired protein fused to N-terminal 6xHis-tag. NSMCE2 protein was 
expressed in Escherichia coli BL21 and purified by Ni+2 affinity chromatography. The purified 
protein was then dialysed by using Slide A-lyser Dialysis Cassettes (Pierce).  
The recombinant full‐length murine NSMCE2 fused to His-tag was used to immunize two 
rabbits in order to generate rabbit polyclonal (VivoTecnia, Spain). The antibodies were the 
purified using Affi‐Gel columns (Bio‐Rad) previously coated with immobilized GST‐NSMCE2 
protein. 
 
3.3 - Cellular fractionation and immunoblotting 
For whole cell protein extracts cells were washed and resuspended in 50 mM Tris pH 7.09 / 
8M Urea / 1% Chaps and placed at 4°C on agitation for at least 30 minutes.  
Cytosolic and nuclear extracts were prepared as previously described (Lecona et al., 2008). 
In order to isolate the cytosolic fraction cells were resuspended with ice-cold hypotonic lysis 
buffer (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA containing protease and 
phosphatase inhibitors) and incubated for 10 minutes on ice. Then, NP-40 (Sigma) was 
added and after 3 minutes, the samples were mixed, centrifuged at 2500g for 2 minutes and 
the supernatant was collected (cytosolic fraction). The pellet was then resuspended in high-
salt concentration extraction buffer (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA 
containing protease and phosphatase inhibitors) and the extract was left shaking at 4°C for at 
least 30 minutes. The samples was spun down at maximum speed and the supernatant 
collected (soluble nuclear fraction). In order to obtain chromatin bound-proteins, 50mM Tris 
pH 7.9/ 8 M Urea/ 1% Chaps was added to the pellet that was incubated with shaking at 4˚C 
for at least 30 minutes. The extract was centrifuged at maximum speed and the supernatant 
collected (chromatin fraction). In order to isolate the total nuclear extract, high-salt-
concentration extraction buffer (20 mM HEPES, pH 7.9, 0.6 M NaCl, 1 mM EDTA containing 
protease and phosphatase inhibitors) was added to the pellet after the isolation of the 
cytosolic fraction. The sample was incubated shaking at 4°C for 10min, sonicated briefly until 
it was clear and incubated for at least 30 minutes more. The total nuclear extract was then 
isolated by centrifugation at max speed. Protein concentration of the extracts was measured 
by Bradford method. 
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NuPage loading buffer (Life technologies) was added to the normalised samples that were 
heated for 10 minutes at 70°C, and separated in gradient gels 4-12% SDS-PAGE (NuPAGE 
4-12%  Bis-Tris Gel, Invitrogen). Proteins were subsequently wet-transferred to nitrocellulose 
membranes (Hybond ECL Nitrocellulose, Amersham). After transfer, membranes were 
blocked for 30 minutes at room temperature in 5% skimmed milk (Central Lechera Asturiana) 
in TBS/0.1% Tween20 (TBS-T) and incubated overnight at 4°C with primary antibodies 
diluted in TBS-T/5% BSA. After washing the membranes 3 times with TBS-T, they were 
incubated for 1 hour at room temperature with HRP-conjugated secondary antibodies.  
Proteins were visualized with SuperSignal West Pico Chemiluminescent Substrate (Life 
technologies) on a ChemiDoc XRS Gel Photo Documentation System (Bio-Rad). 
 
3.4 - Co-immunoprecipitation 
Proteins interaction was evaluated in total nuclear extracts of U2OS cells in untreated 
conditions and in response to 5 µM ICRF-193 treatment for 6 hours. The extract was diluted 
to the desired amount to reduce the amount of NaCl to 200 mM with 25 mM Tris-HCl-0.5 mM 
EDTA. The sample was centrifuged to remove protein precipitates that can occur at low salt. 
The protein extract was treated with 50 µg/ml ethidium bromide (Biorad) to disrupt DNA 
structure. This step is essential to avoid false positive interactions coming from the proteins 
being associated to the same DNA fragment. 
Dynabeads® Protein G (Life Technologies) were washed with BC200 buffer (200 mM NaCl, 
25 mM Tris-HCl and 0.5 mM EDTA) and blocked with 0.5 µg/µl BSA. Blocked magnetic 
beads were incubated for 30 minutes at 4ºC with the desired antibodies. After washing the 
beads 5 times to remove unbound antibodies, the extract was incubated with the magnetic 
beads for 16 hours at 4ºC. The beads were further washed 5 times with BC200 buffer 
containing 0.05% NP-40 (Sigma). Finally, the proteins associated with the magnetic beads 
were eluted with 1X NuPage loading buffer containing 12.5 mM 1,4-Dithiothreitol (DTT, 
Sigma) by incubating the beads at 70ºC for 10 minutes. 
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1 – Roles of NSMCE2 in genome maintenance and replication 
 
 
1.1 - NSMCE2 recruitment to inter- and intra-strand crosslinks 
In order to understand the functions of the SMC5/6 complex in mammals, we focused our 
studies on the SUMO ligase NSMCE2, which is an integral part of the SMC5/6 complex. 
NSMCE2 holds one of the catalytic activities of the complex and it was shown to be essential 
in yeast. With the use of various hypomorhic mutants, NSMCE2 (Mms21 in Saccharomyces 
cerevisiae) was found to participate in the processing of recombinogenic structures induced 
by the treatment with alkylating agents (Branzei et al., 2006). To investigate whether a similar 
response operates in mammals, wild-type MEFs were treated for one hour with MMS and let 
to recover for 24 hours in the absence of the drug. Exposure to MMS promoted the 
accumulation of NSMCE2 foci, supporting the role of the SMC5/6 complex in dealing with 
alkylating agents-induced damage (Figure 1). Noteworthy, MMS-induced NSMCE2 foci in 
MEFs localized preferentially to pericentric heterochromatin, consistent with a preferential 
role of the SMC5/6 complex in the maintenance of repeated sequences. While NSMCE2 foci 
colocalized with H2AX phosphorylation (H2AX) foci in response to MMS, the colocalization 
was not that evident in response to IR, which induced much fewer NSMCE2 foci, suggesting 
that the lesions recognized by NSMCE2 in response to MMS are distinct from DSBs. 
 
  
 
 
Fig. 1 - NSMCE2 foci in response to IR 
and MMS. 
IR‐ (10 Gy and 1 hour recovery) and MMS‐ 
(1 mM for 1 hour and 24 hour recovery) 
induced NSMCE2 and γH2AX foci in MEFs. 
Upon IR, low intensity foci of NSMCE2 are 
observed and these accumulations do not 
colocalize with H2AX. In response to 
MMS, NSMCE2 forms heterochromatic 
foci colocalizing with H2AX. Scale bar 
indicates 5 μm.  
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Another strategy to assess the recruitment of proteins to sites of DNA damage is based on 
the use of a laser-microdissector. The advantage of using this approach resides in the 
possibility to select the region where damage is induced so that the recruitment of the 
desired protein can be easily visualised. When a UV-A laser is used in combination with a 
psoralen treatment, this method can be used for the local generation of ICLs. Psoralen and 
angelicin are able to intercalate in the double helix forming a covalent bond with a DNA 
strand when stimulated by a photon reaction. Since psoralen contains two photochemically 
reactive sites can be used to induce ICLs. Angelicin contains only one reactive site and, 
therefore, it will create mono-adducts upon UV-A stimulation.  
To perform localized ICL experiments, I visited the laboratory of Dr. John Rouse at the 
University of Dundee where these experiments were conducted. By using this technology we 
were able to detect the recruitment of NSMCE2 to sites of UV-A damage in cells treated 
either with psoralen or angelicin (Figure 2), providing the first direct demonstration of the 
recruitment of the SMC5/6 complex to ICLs. 
 
 
 
 
 
 
 
 
Fig. 2 - NSMCE2 recruitment to laser-induced ICLs. 
A UV-A coupled laser microdissector was used in combination with 50 µM psoralen for 1 hour or 50 µM 
angelicin for 1 hour to evaluate the recruitment of NSMCE2 to sites of inter- or intra-strand crosslinks. 
Recruitment was assessed 30 minutes after inducing the damage. Scale bar indicates 10 μm. H2AX was 
used to mark the sites of damage. 
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1.2 - NSMCE2 suppresses recombination and facilitates chromosome 
segregation 
Our next aim was to evaluate the consequences of deleting Nsmce2 in mammalian cells and 
organisms. To this end, a conditional knockout strain was generated (Jacome et al., 2015). 
When combined with a strain that expresses a tamoxifen inducible version of the Cre 
recombinase from the ubiquitin promoter (Ub.CreERT2), this system allows for the controlled 
depletion of NSMCE2 (Figure 3a). The first observation, consistent with the essential role of 
all SMC5/6 complex members, was that loss of NSMCE2 in MEFs severely impaired cell 
growth as demonstrated by clonogenic assays (Figure 3b). To investigate the causes of the 
reduced viability of NSMCE2-deficient cells, Ub.CreERT2 Nsmce2lox/lox MEFs were plated in 
presence and without 4-OHT and cultured for 8 days. Nuclei morphology was then evaluated 
by DAPI staining. Loss of NSMCE2 protein resulted in a variety of nuclear abnormalities 
indicative of segregation problems with micronuclei being the most represented (Figure 3c-
3d). We also detected cells presenting highly irregular and multilobulated nuclei, which are 
likely the consequence of cumulative segregation problems during serial passaging. Of note, 
Cre expression in mammalian cells has been previously shown to slow down proliferation 
due to the fact that it creates DNA breaks (Loonstra et al., 2001). To discard the possibility 
that our phenotypes were influenced by the endonuclease activity of Cre, Ub.CreERT2 
Nsmce2+/+ MEFs were also included in the study. The presence of the Cre recombinase 
within the nucleus only minimally increased the percentage of segregation defects and did 
not visibly impair proliferation, confirming that the observed effects were due to NSMCE2 
deficiency. Of note, NSMCE2 depletion did not affect the levels of chromatin-bound SMC5, 
suggesting that an NSMCE2-devoid SMC5/6 complex is not functional even if recruited to 
chromatin (Figure 4). 
Problems in chromosome segregation can arise either from true mitotic problems, but also 
from deficient DNA replication and repair which can lead to the presence of unreplicated 
regions of the genome reaching mitosis (Mankouri et al., 2013). The resolution of joint DNA 
molecules that reach mitosis is normally carried over by a pathway involving the BLM 
helicase, known as dissolution, and which does not involve DNA breakage (Mankouri et al., 
2013, Mankouri et al., 2011). When dissolution fails and joint DNA molecules persist, a 
nuclease-dependent pathway known as resolution takes place, with the risk of genomic 
rearrangements. This is best exemplified by the large increase in sister chromatid exchanges 
(SCE) present in BLM-deficient cells. Interestingly, NSMCE2‐deficient MEFs presented a 
significant increase in SCE levels (Figure 3e-3f), indicating that its function could be similar 
to that of BLM, and suggesting that deficiencies in DNA replication and/or in the resolution of 
unresolved loci in mitosis could underlie the observed segregation defects.  In support of this, 
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combined deletion of Blm and Nsmce2 is lethal in mouse B lymphocytes (Jacome et al., 
2015). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 - Defects observed in NSMCE2-deficient cells. Modified from Jacome et al. (2015). 
a) Deletion of NSMCE2 assessed by Western blot (WB) in UQ.CreERT2 Nsmce2+/+ and Nsmce2lox/lox MEFs 
after 48 hours of  4‐OHT treatment. Tubulin levels are shown as a loading control. 
b) Clonogenic assay on immortalized UQ.CreERT2 Nsmce2lox/lox MEFs. The picture shows the colonies 
detected after 10 days of growth in the presence or absence of 4‐OHT, upon staining with crystal violet. 
c) Quantification of the various segregation defects that can be observed by DAPI staining in UQ.CreERT2 
Nsmce2+/+ and Nsmce2lox/lox MEFs treated or not with 4-OHT for 8 days. 
d) Examples of segregation defects observed in NSMCE2-deficient MEFs described in c). Scale bar 
indicates 2.5 μm. 
e) SCE events per metaphase on UQ.CreERT2/Nsmce2lox/lox MEFs grown in the presence of 4‐OHT for 
72 hours. The P-value was calculated with unpaired two-tailed t-test. *** P<0.001. 
f) Example of a metaphase with increased levels of SCE due to NSMCE2 loss in MEFs mentioned in e). 
Arrows show the exchange of genetic material between sister chromatids.  
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1.3 - NSMCE2 is not essential for overall DNA replication in mammalian cells  
To determine whether NSMCE2 deficiency has a direct effect on DNA replication, DNA fiber 
analysis was carried out in B-lymphocytes where Nsmce2 was deleted by a Cre recombinase 
system knocked-in at the B-cell specific CD19 promoter (Figure 5a). Since splenic B-cells 
are arrested in G0, this system allows to evaluate the effects of NSMCE2 deficiency in the first 
cell cycle, eliminating the potential damage that could derive from previous cell cycles.  
B-lymphocytes were stained with propidium iodide (PI) and subsequently analyzed by Flow 
cytometry to evaluate their cell cycle progression. As expected, G1 and G2 peaks were 
visible in these cells 48 hours after being stimulated in vitro with LPS. Interestingly, cultures 
of Nsmce2 deleted B-cells presented cells with a >4n amount of DNA, further indicative of 
the segregation defect that arise in the context of NSMCE2 deficiency (Figure 5b). DNA fiber 
analyses performed in these cells revealed that DNA replication was not significantly altered 
by NSMCE2 loss, neither in terms of origin firing, nor on fork rates (Figure 5c-5d-5e). While 
we cannot exclude that NSMCE2 might play a specific role in the replication of certain loci 
(e.g. pericentromeric DNA or repeat regions), these analyses reveal that overall DNA 
replication is not affected by NSMCE2 deficiency in mammalian cells.  
Fig. 4 – Localization of SMC5 is 
not affected by NSMCE2 
depletion. 
Cellular fractionation of Ub.CreERT2 
Nsmce2lox/lox MEFs with and without 
4-OHT treatment. Levels of SMC5 in 
the three fractions are not altered by 
NSMCE2 depletion. 
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Fig. 5 - NSMCE2 is dispensable for DNA replication (Jacome et al., 2015). 
a) WB illustrating the depletion of NSMCE2 in B-lymphocytes isolated from 2 months old CD19+/Cre 
animals of the indicated genotypes, 48 hours after being stimulated in vitro with LPS. Tubulin was used 
as a loading control. 
b) Representative flow cytometry analysis from the B‐lymphocytes cultures mentioned in (a). DNA 
content was measured by PI staining. Note the presence of cells with > 4n DNA content in 
NSMCE2‐deficient cells. 
c-d) Frequency of origin firing (c) and fork rate (d) were analysed by DNA fiber analyses from fibers 
prepared from B‐cell cultures explained in (a). Between 200 and 300 tracks were measured to estimate 
fork rate and 300–500 for the calculation of origin firing frequencies. No significant differences were 
observed between CD19+/Cre Nsmce2+/+ and CD19+/Cre Nsmce2lox/lox B-cells.  
e) Representative images of the DNA fibers used for the analysis explained in (c, d). CldU (red) and IdU 
(green) channels are shown. 
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1.4 - NSMCE2 suppresses ageing in mice independently of its SUMO ligase 
activity 
Finally, and since NSMCE2 is essential for embryonic development, we evaluated the 
physiological impact of deleting Nsmce2 in adult mice. To this end, UQ.CreERT2 Nsmce2lox/lox 
mice were fed with a 4-OHT containing diet starting at weaning. Deletion of the Nsmce2 in 
adult mice led to a progressive and generalised progeroid syndrome (Figure 6a-6b). As 
examples of the overall ageing process, NSMCE2-deficient mice presented premature hair 
greying and reduced body fat (Figure 6c). In addition to the remarkable ageing phenotype, 
these animals presented other hallmarks of genomic instability syndromes such as Bloom’s 
Syndrome or Fanconi anemia, including an altered pigmentation of the skin and progressive 
anemia (Figure 6d).  
 
 
 
 
 
 
 
 
Fig. 6 - Impact of Nsmce2 deletion in adult mice. Modified from Jacome et al. (2015). 
a) UQ.CreERT2 Nsmce2+/+ and Nsmce2lox/lox animals fed for 9 months with a 4‐OHT‐containing diet. 
b) Altered pigmentation of the skin in UQ.CreERT2 Nsmce2lox/lox mice. 
c) Percentage of fat against total body mass on Nsmce2+/+ and Nsmce2lox/lox animals.  The P-value was 
calculated with unpaired two-tailed t-test. *** P<0.001. 
d) White blood cell counts (WBC) from Nsmce2+/+ and Nsmce2lox/lox animals. The P-value was calculated 
with unpaired two-tailed t-test. *** P<0.001. 
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To evaluate the contribution of the SUMO ligase activity to the phenotype observed in vivo, 
mice lacking of NSMCE2 SUMO ligase activity were generated in our lab (Jacome et al., 
2015). Loss of the SUMO ligase activity was achieved by using a knock‐in mutant allele in 
which C185S and H187A mutations were introduced on the SP‐RING domain (Nsmce2SD). In 
contrast to NSMCE2 deficiency, loss of its SUMO ligase activity did not lead to accelerating 
ageing nor to any other apparent phenotype in mice (Figure 7a).  Furthermore, Nsmce2SD/SD 
animals were viable and fertile and showed no alteration of their lifespan (Figure 7b). 
Inactivation of its SUMO ligase also did not affect the recruitment of NSMCE2 to MMS‐ or 
MMC‐induced foci (Figure 7c-7d). 
 
 
 
 
 
 
 
Fig. 7 - Abrogation of NSMCE2 SUMO ligase activity has no effect on mice physiology. 
Modified from Jacome et al. (2015). 
a) Representative picture of 6 months old Nsmce2+/+ and Nsmce2SD/SD mice. 
b) Survival curves of Nsmce2+/+ and Nsmce2SD/SD mice. The P‐value was calculated with the Mantel–Cox 
long‐rank test. 
c) NSMCE2 foci in MMS‐treated Nsmce2+/+ and Nsmce2SD/SD MEFs. Scale bar indicates 2.5 μm. 
d) High-Throughput Microscopy (HTM) mediated quantification of the number of NSMCE2 foci per cell in 
wild-type and Nsmce2SD/SD MEFs in response to MMS (1 mM for 1 hour and 16 hour recovery) or MMC 
(0.25 μM for 16 hours).  
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In summary, in this first part of the PhD we revealed that NSMCE2 suppresses 
recombination and segregation problems in mammalian cells, and performed a first general 
characterization of the impact of NSMCE2 deficiency in an adult organism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
78 
2 - NSMCE2 deficiency in mice leads to karyomegalic interstitial 
nephritis. 
 
 
2.1 - Post-natal Nsmce2 deletion leads to Karyomegalic Interstitial Nephritis 
Karyomegalic interstitial nephritis (KIN) is a late-onset degenerative disease of the kidney, in 
which giant nuclei progressively accumulate in the cortex until kidney dysfunction ensues 
(OMIM 614817). The discovery that mutations in FAN1, a nuclease involved in ICL repair 
(Zhou et al., 2012, Smogorzewska et al., 2010) are a cause oh hereditary KIN in humans, 
indicated that DNA damage accumulation could underlie the ontogeny of this disease (Zhou 
et al., 2012). Later work confirmed the role of FAN1, as FAN1 deficiency in mice leads to a 
mild form of KIN (Lachaud et al., 2016, Thongthip et al., 2016). To date, FAN1 is the only 
gene that has been identified as a cause of KIN.   
Besides the overall progeria that is observed in NSMCE2-deficient adult mice, a careful 
analysis of the different organs revealed a distinct phenotype on their kidneys that worsened 
as the mice age. Macroscopically, kidneys of NSMCE2-deficient mice were smaller and of a 
lighter colour compared to the ones isolated from wild-type littermates (Figure 8a). This 
pathology tended to proceed asymmetrically, with one of the kidneys ultimately reducing its 
size (Figure 8b). Renal histology through Hematoxylin-Eosin staining revealed the hallmark 
of KIN, which is the presence of karyomegalic cells in the renal cortex of NSMCE2-deficient 
animals (Figure 8d). Quantification of the nuclear area of kidney cells confirmed the 
presence of larger nuclei in the cortex of NSMCE2-deficient kidneys, where nuclear size 
could reach up to 200 µm2 (Figure 8e). This peculiar alteration occurs specifically in the 
epithelial cells forming the renal tubuli of the cortex, whereas no major alteration in nuclear 
size was found in the renal medulla. Together with the presence of giant nuclei, the entire 
kidney architecture of NSMCE2-deficient mice appears disorganized, with irregular nuclei 
and areas of severe tubuli dilation (Figure 8c-8d). As observed in human KIN patients, the 
kidneys of NSMCE2-deficient mice presented a progressive accumulation of fibrotic tissue as 
detected by a Masson’s Trichrome-staining (Figure 8f). Noteworthy, and in contrast to what 
was reported in the kidneys of FAN1-deficient mice (Lachaud et al., 2016), we failed to detect 
H2AX positive staining in the enlarged tubular cells observed on NSMCE2-deficient kidneys 
(Figure 8g). The onset of the KIN phenotype (as well as the progeria) varies from mouse to 
mouse likely reflecting the variability on Nsmce2 deletion that occurs with the 4-OHT-
containing diet. 
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Fig. 8 - Hallmarks of  KIN in Nsmce2 conditional knockout mice. 
a) Kidneys from 9 months old UQ. CreERT2 Nsmce2+/+ and UQ. CreERT2  Nsmce2lox/lox. Scale bar indicates 5 mm. 
b) Representative example of kidney shrinkage observed in a 12 months old UQ. CreERT2  Nsmce2lox/lox mice on a 4-
OHT diet. Scale bar indicates 5 mm. 
c) Severe tubular dilation observed in UQ. CreERT2  Nsmce2lox/lox mice on a 4-OHT diet. Scale bars indicates 20 µm. 
d) Histological analysis by hematoxylin-eosin staining of kidneys from Nsmce2+/+ and Nsmce2lox/lox mice, 10 months 
after being fed with a 4-OHT containing diet. Cells in renal tubular epithelia (black arrow) and partial dilation of 
renal tubules (asterics) are observed. Scale bars indicates 20 µm.  
e) Quantification of nuclear area in the different renal compartments. The P-value was calculated with unpaired 
two-tailed t-test. *** P<0.0001 
f) Analysis of fibrosis (in blue) by Masson’s Trichrome staining in renal sections from wild-type and UQ. CreERT2  
Nsmce2lox/lox mice 10 months after being fed with a 4-OHT containing diet. Scale bars 20 µm. 
g) H2AX staining in kidneys of 10  months old UQ. CreERT2  Nsmce2lox/lox mice fed with 4-OHT diet. 
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In order to evaluate whether the KIN phenotype compromised the physiology of the organ, 
blood analyses were performed looking at markers of kidney function. To this end, levels of 
urea, creatinine and albumin were analysed in blood serum. Urea and creatinine are internal 
waste metabolites that need to be expelled into the urine through the kidneys. If kidney 
function is impaired, these compounds are not properly filtered and their blood levels rise. 
Indeed, NSMCE2-deficient mice present higher urea and creatinine levels in blood compared 
to wild-type mice, indicating that kidney function is compromised in these mice (Figure 9). In 
contrast to waste metabolites, albumin is a valuable compound that needs to be retained in 
the bloodstream. The size of the molecule prevents its filtration through the kidney. However, 
if glomeruli structure is disrupted and its filtration ability compromised, it is expelled into the 
urine resulting in a decrease of albumin in blood. Lower levels of albumin in the blood 
NSMCE2-deficient mice further confirmed renal dysfunction (Figure 9). The low amount of 
urine that we could obtain (particularly from mutant animals), prevented an analogous 
analysis of the urine. Taken together, these data suggests indicate that NSMCE2 deficiency 
in adult mice leads to KIN, which ultimately compromises kidney function. 
 
 
 
 
 
 
 
 
 
Fig. 9 - Nsmce2 deletion in adult mice leads to kidney failure. 
Urea, Creatinine and Albumin levels in blood serum of UQ. CreERT2 Nsmce2+/+ and UQ. CreERT2  Nsmce2lox/lox 
between 50 and 55 weeks of age fed with 4-OHT containing diet starting at eaning. Each dot represents 
an independent mouse.  The P-value was calculated with unpaired two-tailed t-test. *= P<0.01; **= 
P<0.001; *** P<0.0001. 
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2.2 - NSMCE2-dependent SUMOylation is dispensable for normal kidney 
function 
In order to evaluate if the observed KIN was related to the SUMO ligase activity of NSMCE2, 
a careful analysis of the kidney was also performed in Nsmce2SD/SD mice. In contrast to what 
we observed in NSMCE2-deficient animals, kidney shape, size and colour did not differ 
between wild-type and SUMO-dead animals (Figure 10a). In addition, immunohistochemistry 
analyses failed to detect karyomegalic cells, tubular dilation or fibrosis in the mutant kidneys 
(Figure 10b-10c). In summary, loss of the SUMO ligase activity of NSMCE2 has no 
detectable impact on kidney physiology.  
 
 
 
 
 
Fig. 10 - Nsmce2SD/SD mice have no signs of KIN. 
a) Kidneys from 15 months old Nsmce2+/+ and Nsmce2SD/SD mice. Scale bar indicates 1 cm.  
b) Histological analysis by hematoxylin-eosin staining of renal cortex from 12 months old Nsmce2+/+ and 
Nsmce2SD/SD mice. No karyomegalic cells were found. Scale bars indicates 20 µm. 
c) Analysis of fibrosis (in blue) by Masson’s Trichrome staining in renal sections from Nsmce2+/+ and Nsmce2SD/SD 
mice. Scale bars indicates 20 µm. 
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2.3 - NSMCE2 is recruited to sites of topological stress 
From clinical cases of KIN that have been reported in the literature, some of them have been 
associated with the exposure to ochratoxin A (OTA) (Hassen et al., 2004, Godin et al., 1996), 
a mycotoxin produced by several species of Aspergillus and Penicillium that is sometimes 
found as a food contaminant. The patients of KIN exposed to OTA presented all the 
hallmarks of the disease. In addition, OTA can be used to induce KIN experimentally in mice 
and rats (Adler et al., 2009, Vettorazzi et al., 2011, Taniai et al., 2014). However, for a long 
time the mechanism of action of OTA-induced nephrotoxicity was unknown. Finally, in 2009 
Cosimi and colleagues demonstrated that OTA was a catalytic inhibitor of DNA 
topoisomerase II (TOPOII), although this study did not connect this finding to the ontogeny of 
KIN.  
Abundant work from model organisms had already shown that the functions of the SMC5/6 
complex are related to Topoisomerases (Kegel et al., 2011, Jeppsson et al., 2014). To 
investigate if mammalian NSMCE2 was responsive to topological stress we first evaluated 
the distribution of NSMCE2 after exposing cells to either Etoposide (a topoisomerase poison 
that generates breaks due to the trapping of an intermediate product) or ICRF-193 (a 
catalytic inhibitor of TOPOII) in mouse NIH-3T3 cells (Huang et al., 2001). Under these 
conditions, NSMCE2 is dramatically concentrated around pericentric heterochromatin, in foci 
that also contain γH2Ax (Figure 11a). We should note that from all conditions we ever tested 
in the laboratory (including IR, HU, DNA repair inhibitors, etc…) to induce NSMCE2 foci, the 
catalytic inhibitor ICRF-193 is the one that promotes the most intense recruitment of 
NSMCE2 (Figure 11b).  
TOPOII inhibition and NSMCE2 deficiency also share a peculiar phenotype, the presence of 
diplochromosomes. Diplochromosomes consist of four chromatids held together and are the 
visual sign of mitotic defects. Although the true source of diplochromosomes is unknown, 
they are thought to be linked to endoreplication, namely two rounds of DNA replication 
without mitotic division and therefore, without chromatid separation (Sumner, 1998, Cortés 
and Pastor, 2003). One of the few conditions that has been shown to experimentally induce 
diplochromosomes in mammalian cells is the inhibition of TOPOII (Sumner, 1998, Ji et al., 
2009, Cortés and Pastor, 2003). Interestingly, metaphase spreads from Nsmce2 conditional 
knockout MEFs presented several diplochromosomes (Figure 12a-12b), once again 
reinforcing the link between NSMCE2 and Topoisomerase activity. The visualization of these 
structures was facilitated by labelling the telomeres of each chromatid with distinct probes by 
CO-FISH staining, which was performed with the help of the group of Dr. Maria Blasco at the 
Spanish National Cancer Research Center. 
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Fig. 12 - Loss of NSMCE2 leads to diplochromosomes. 
a) Diplochromosomes are found in the metaphase spreads of UQ. CreERT2  Nsmce2lox/lox MEFs treated with 
4-OHT for 48 hours to delete Nsmce2. For better visualization of these structures, CO-FISH was used to 
mark telomeric ends. The hybridization of a strand-specific telomeric probe allowed to distinguish the 
orientation of the chromatid. 
b) Quantification of the metaphases characterized by the presence of diplochromosomes in cells 
mentioned in a).  
 
Fig. 11 - NSMCE2 is recruited to topological stress. 
a) NSMCE2 foci colocalizing with H2AX in 3T3 cells in response to MMC (300 nM for 6 hours), 
Etoposide (0.5 µM for 6 hours) and ICRF-193 (5 µM for 6 hours). Scale bar 5 µm. 
b) Quantification of NSMCE2 foci per cell in 3T3 cells upon MMC, Etoposide and ICRF-193 treatment. 
The P-value was calculated with unpaired two-tailed t-test. *** P<0.0001 
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2.4 - Response of NSMCE2-deficient cells to Topoisomerase inhibition 
As mentioned, SMC5/6 deficiencies and TOPOII inhibition share similar phenotypes and are 
both involved in pathways of DNA topology maintenance. It is well known that their actions in 
yeasts are epistatic and their combined deficiency results in synthetic lethality due to severe 
segregation defects (Takahashi et al., 2008, Outwin et al., 2009, Jeppsson et al., 2014). In 
order to investigate the relationship between NSMCE2 and TOPOII in mammalian cells, we 
explored the sensitivity of NSMCE2-deficient cells to TOPOII poisons.  First, we evaluated 
the response of CD19+/Cre Nsmce2+/+ and Nsmce2lox/lox B-lymphocytes to the catalytic 
inhibition of TOPOII (Figure 13a). Cell survival was assessed to a range of ICRF-193 
concentrations by scoring DAPI-positive dead cells by flow cytometry. While ICRF-193 was 
toxic for B-cells, there was still no clear sensitivity of Nsmce2 knockout cell to TOPOII 
inhibition. However, one limitation of this approach is that NSMCE2 deficiency had already a 
very severe effect on cell survival in B-cells, which could likely mask the effect of any 
additional treatment (Figure 13b-13c).  
Next, the sensitivity to ICRF-193 was assessed in Nsmce2 conditional knockout MEFs by a 
CellTiter-Glo® Luminescent Cell Viability Assay, which measures mitochondrial activity. Like 
in the case of B-cells, NSMCE2 deficiency in MEFs resulted by itself in a clear reduction in 
proliferation and no clear additional impact of the drug was observed (Figure 13d).   
Since the cell-essential nature of NSMCE2 limited the analysis in terms of survival, we 
focused on analysis on segregation defects. While ICRF-193 treatment does not result in 
increased cell death, it aggravated the segregation defects present in Nsmce2 mutant cells. 
For instance, flow cytometry analyses revealed the presence of a tetraploid peak in 
NSMCE2-deficient B-cells exposed to ICRF-193 (Figure 14a-14b). In addition, NSMCE2 
conditional knockout MEFs accumulated more DNA bridges than wild-type MEFs when 
treated with the TOPOII inhibitor (Figure 14c). These bridges are positive for the H3K9m3, 
which by immunofluorescence in mouse cells it mostly marks pericentromeric chromatin, 
suggesting that these structures might arise from the missegregation of centromeric regions 
(Figure 14d). Besides segregation problems, TOPOII inhibition also increased the number of 
chromosome breaks that were induced by ICRF-193 in NSMCE2-deficient B-cells (Figure 
15a-15b).  
In summary, our data support that a key role of the SMC5/6 complex in the response to 
topological stress, exemplified by the recruitment of NSMCE2 to sites of TOPOII induced 
damage and that NSMCE2 deficiency phenocopies many of the effects of TOPO II inhibition. 
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Fig. 13 - Nsmce2 knockout cells are not more sensitive than wild-type cells to TOPOII 
inhibition. 
a) WB illustrating the depletion of NSMCE2 in CD19+/Cre Nsmce2+/+ and Nsmce2lox/lox B-cells, 48 hours after 
being stimulated in vitro with LPS. Tubulin was used as a loading control. 
b) Viability assay by DAPI staining of CD19+/Cre Nsmce2+/+ and Nsmce2lox/lox B-cells. Cells were stimulated 
with LPS for 24 hours followed by 24 and 48 hours treatment with a range of ICRF-193 concentrations (0-
15 µM). 
c) Percentages of cell survival, obtained by flow cytometry analysis measuring DAPI incorporation in 
CD19+/Cre Nsmce2+/+ and Nsmce2lox/lox B-cells described in (a) exposed to a range of ICRF concentration (0-
15 µM) for 24 and 48 hours. 
d) Normalized survival from CellTiter-Glo® Luminescent Cell Viability Assay of UQ. CreERT2 Nsmce2+/+ and 
Nsmce2lox/lox MEFs treated with 4-OHT for 48 hours to induce Nsmce2 deletion, followed by ICRF-193 (0-1 
µM) treatment for 48 hours. 
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Fig. 14 - TOPOII inhibition and Nsmce2 deletion impair chromosome segregation. 
a) Representative flow cytometry analysis from the B-cell cultures. DNA content was measured with 
HOECHST staining. Note the presence of cells with >4n DNA content in NSMCE2-deficient B-cells treated 
with 0.1 µM ICRF-193 for 24 hours.  
b) Quantification of cells with >4n DNA content in CD19+/Cre Nsmce2+/+ and Nsmce2lox/lox B-cells 
mentioned in (a). 
c) Percentage of micronuclei and DNA bridges in UQ. CreERT2 Nsmce2+/+ and Nsmce2lox/lox MEFs treated 
with 4-OHT for 48 hours to induce Nsmce2 deletion and with 0.5 µM ICRF-193 for the last 16 hours. 
d) Representative ICRF-193-induced missegregation of centrometic regions marked for H3k9m3. Scale 
bar  indicates 10 µm. 
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Fig. 15 - Chromosomal defects in NSMCE2-deficient cells treated with TOPOII poisons. 
a) Metaphases spreads of CD19+/Cre Nsmce2+/+ and Nsmce2lox/lox B-cells, stimulated for 48 hours with LPS 
and treated with 0.5 µM ICRF-193 for the last 16 hours. TOPOII inhibition in knockout cells results in 
increased chromosome breaks (arrows).  
b) Quantification of number of breaks per metaphases mentioned in (a). 
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2.5 - NSMCE2 deficiency increases the levels of chromatin loaded TOPOII 
Since the best indicator of topological stress could be the presence of Topoisomerases, we 
evaluated the levels of chromatin-bound TOPOII in Nsmce2 conditional knockout MEFs by 
High-Throughput Microscopy (HTM). To enhance TOPOII recruitment, cells were also 
exposed to ICRF-193 for one hour. Interestingly, the levels of chromatin-bound TOPOII were 
constitutively higher in NSMCE2-deficient cells, a difference that was increased in the 
presence of ICRF-193 (Figure 16a-16b). These data further support an important role of 
NSMCE2 in suppressing topological stress.  
 
 
 
 
 
 
 
2.6 - FAN1 and NSMCE2 are both involved in processing DNA topological 
stress 
To date, the only mutation found in human patients of KIN is a mutation in a gene encoding 
the nuclease FAN1 (Zhou et al., 2012). FAN1 was originally described to be part of the 
Fanconi Anemia (FA) pathway because of its direct interaction with ubiquitinated FANCD2, a 
key event of the FA pathway (Smogorzewska et al., 2010, MacKay et al., 2010). These 
Fig. 16 - TOPOII accumulates at centromeres in Nsmce2 conditional knockout cells. 
a) Representative images of TOPOII foci intensities in UQ. CreERT2  Nsmce2lox/lox MEFs with and without 4-
OHT treatment for 48 hours. Scale bar  indicates 5 µm. 
b) Quantification of TOPOII intensity in MEFs described in a) in untreated condition and upon treatment 
of 10 µM ICRF-193 for 1 hour. 
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original studies placed FAN1 as a central player in ICL repair and thus in the FA pathway. 
However, human FAN1 mutant patients do not present Fanconi Anemia (Trujillo et al., 2012), 
raising doubts on whether the true physiological role of FAN1 is on ICL repair. 
 
 
 
 
 
 
 
 
 
Fig. 17 - NSMCE2 and FAN1 are both involved in topological stress. 
a) Colocalization of NSMCE2 and GFP-FAN1 foci in 3T3 cells treated in response to MMC (300 nM for 6 
hours) and ICRF-193 (5 µM for 6 hours). Scale bar indicates 5 µm. 
b) Quantification of cells with >2 NSMCE2 and FAN1 foci in the different treatments mentioned in (a). 
c) Percentage of colocalization expressed as total number of cells with NSMCE2-FAN1 colocalization out 
of the total number of cells with >2 NSMCE2 foci. 
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Our data with NSMCE2-deficient mice, and the fact that the KIN induced agent OTA is a 
TOPOII catalytic inhibitor, led us to explore whether there could also be a connection 
between FAN1 and topological stress, and between FAN1 and NSMCE2. To this end, we 
first use a GFP-FAN1 construct that was transiently transfected in 3T3 cells. FAN1 foci were 
monitored after treatment with the TOPOII poison ICRF-193 and the ICL-inducing agent 
MMC. FAN1 formed foci in heterochromatin upon both treatments that colocalized with 
NSMCE2 foci (Figure 17a). Of note, even though they colocalized, the two proteins 
presented different patterns of foci with FAN1 forming smaller accumulations. As in the case 
of NSMCE2, FAN1 foci formation was better induced by ICRF-treated cells than by MMC 
treated (Figure 17b-17c). Whereas all current studies have focused on the role of FAN1 in 
ICL repair, our data presents the first evidences of a role for this protein in the response to 
topological stress.  
 
2.7 - SMC5/6 complex does not physically interact with FAN1 
Given the colocalization of FAN1 and NSMCE2, the potential physical interaction between 
FAN1 and the SMC5/6 complex was investigated. To this end, co-immunoprecipitation 
assays were carried out in U2OS cells in untreated condition, and after ICRF-193 treatment, 
to see if their potential interaction could take place exclusively upon TOPOII inhibition. As 
expected, the pull-down of SMC5 immunoprecipitated NSMCE2 (Figure 18).  
 
 
 
 
 
Fig. 18 - NSMCE2, FAN1 and TOPOII do not interact physically. 
Co-immunoprecipitation assay in U2OS showing no physical interaction between SMC5, FAN1 and 
TOPOII in untreated condition (left panel) and upon 6 hours 5 µM ICRF-induced damage (right panel). 
Extracts were treated with ethidium bromide to avoid false positive interactions. 
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However, the SMC5/6 complex does not interact directly with FAN1, although sharing the 
same localization on chromatin. In addition, TOPOII was not found in SMC5 and FAN1 pull-
downs. We shall note that another recent report has shown coimmunoprecipitation of TOP2A 
with SMC5/6 (Verver et al., 2016), but we have failed to see this interaction in our 
experimental conditions. Nevertheless, the absence of a physical interaction does not 
exclude that both complexes might be operating on a common substrate. 
 
2.8 - FAN1 and NSMCE2 are independently recruited to the site of damage 
We next investigated whether the recruitment of FAN1 and NSMCE2 is dependent on each 
other. First, we measured NSMCE2 recruitment in MEFs where Fan1 was deleted using the 
CRISPR-Cas9 technology (Figure 19a). These cells presented a lower number NSMCE2 
foci in response to MMC and ICRF-193 treatment compared to wild-type cells (Figure 19b-
19c). Accordingly, H2AX staining was also less intense (Figure 19d). These data suggest 
that FAN1-deficient cells display reduced DNA damage by either affecting proliferation or by 
impairing the recruitment of DNA repair factors, such as NSMCE2, that are essential to boost 
the DNA damage response. At this point we must be cautious in the interpretation of these 
results, since the formation of foci can be influenced by replication rates. In any case, they do 
show that NSMCE2 can be recruited independently of FAN1. 
Next, we investigated NSMCE2 recruitment in MEFs lacking FAN1 nuclease activity 
(Fan1KI/KI, kind gift of Dr. John Rouse). First, biochemical fractionation experiments showed 
that the lack of nuclease activity did not affect the overall levels of chromatin-bound NSMCE2 
(or SMC5) (Figure 19e). Next, we investigated the dynamics of NSMCE2 recruitment to ICLs 
using psoralen-induced laser stripes in wild-type and FAN1 nuclease deficient MEF. 
Surprisingly, and in contrast to our observations in MMC-induced foci, NSMCE2 accumulates 
more intensely at psoralen-induced laser stripes in Fan1KI/KI MEFs (Figure 19f). However, 
this is due to the higher load of damage that is induced by the treatment in the mutant MEFs, 
as reflected by a higher amount of H2AX phosphorylation at the laser stripes. In any case, 
both datasets converge in that NSMCE2 recruitment is not dependent on FAN1 or its 
nuclease activity. 
In regards to FAN1 recruitment, the severe proliferation deficiency of Nsmce2-deleted cells 
while precluded a proper analysis of this by foci experiments, nevertheless chromatin 
fractionation experiments revealed that FAN1 recruitment to chromatin could still occur in the 
absence of NSMCE2 (Figure 20). In summary, while FAN1 and NSMCE2 seem to recognize 
similar insults, they can do it independently. 
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Fig. 19 - NSMCE2 recruitment is not dependent on FAN1. 
a) WB illustrating the deletion of Fan1 by CRISPR-Cas9 technology in MEFs. Control cells were infected 
with control sgRNA and 3 different sgRNAs were used to target the Fan1 allele. Tubulin used as a loading 
control. 
b) NSMCE2 foci in wild-type and Fan1 knockout MEFs, treated with 300 nM MMC for 6 hours and 5µM 
ICRF-193 for 6 hours. Scale bar indicates 10 µm. 
c) Quantification of foci mentioned in (b) 
d) Analysis of H2AX intensity by HTM in wild-type and Fan1 knockout MEFs, treated with 300 nM MMC 
for 6 hours and 5 µM ICRF-193 for 6 hours.  
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2.9 - NSMCE2 and FAN1 are not epistatic  
To gain further insights into the potential relationship between FAN1 and NSMCE2, double 
mutant cells were generated by using CRISPR-Cas9 technology to target Fan1 in Nsmce2 
conditional knockout MEFs (Figure 21a).  These experiments revealed that the deletion of 
both Nsmce2 and Fan1 did not significantly increase the presence of segregation problems 
such as micronuclei or DNA bridges (Figure 21c). These experiments confirmed the 
segregation problems induced by TOPOII inhibition of NSMCE2-deficient cells. In contrast, 
we did not observe any obvious impact of FAN1 deficiency in response to TOPOII inhibition, 
and the double mutant was as compromised as the single Nsmce2 mutant. While we cannot 
discard that FAN1 might play some role in the response to topological stress under other 
conditions, these experiments show that the function of NSMCE2 in this response is 
independent of FAN1.   
e) NSMCE2 and SMC5 levels in total, cytosolic, soluble nuclear and chromatin fractions in wild-type and 
Fan1KI/KI MEFs. 
f) NSMCE2 recruitment to psoralen-induced laser stripes in Fan1KI/KI MEFs. H2AX was used to mark the 
sites of damage. 
 
 
Fig. 20 - FAN1 localization is not 
affected by NSMCE2 loss. 
Cellular fractionation of UQ. CreERT2 
Nsmce2lox/lox treated for 48 hours with 
4-OHT to induce Nsmce2 deletion. 
Levels of chromatin-bound FAN1 do 
not vary in these cells. 
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Fig. 21 - NSMCE2 and FAN1 are not epistatic. 
a) WB illustrating the generation of Fan1-Nsmce2 double mutant MEFs. UQ. CreERT2 Nsmce2lox/lox were 
infected with control sgRNA (lane 1) and treatment with 4-OHT of these cells generated Nsmce2Δ/Δ 
(lane2). 3 different sgRNAs were used to target Fan1 allele in UQ. CreERT2 Nsmce2lox/lox (lane 3). 
Treatment with 4-OHT of Fan1 knockout MEFs generated Nsmce2-Fan1 double knockout cells. Tubulin 
used as a loading control. 
b) Analysis of segregation defects (DNA bridges and micronuclei) induced by 16 hours ICRF-193 
treatment in cells described in (a). 
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Discussion  
 
Using mouse as a model system, our work shows that NSMCE2 is essential for embryonic 
development and that its post-natal deletion leads to accelerating ageing independently of its 
SUMO ligase activity. At the cellular level, the essential role of NSMCE2 resides in facilitating 
chromosome segregation likely through eliminating joint DNA molecules before they reach 
mitosis. In agreement with this view, NSMCE2 deficiency leads to a significant increase in 
Sister Chromatid Exchange (SCE) events, which arise through the processing of joint DNA 
molecules by structure-specific nucleases (Matos and West, 2014, West et al., 2015, Wyatt 
et al., 2013). Our current work supports that one key source of joint DNA molecules that is 
dealt by NSMCE2 (and, thus, by the SMC5/6 complex) are topological intertwines. 
Accordingly, NSMCE2 deficiency increases the levels of chromatin bound TOPOII, 
phenocopies several outcomes that arise upon TOPOII inhibition, and sensitizes cells to the 
effects of TOPOII inhibitors. In vivo, NSMCE2 deficiency leads to KIN, a kidney disorder that 
in humans was associated to exposure to OTA (TOPOII inhibitor) (Godin et al., 1996, 
Hassen et al., 2004, Cosimi et al., 2009), and to FAN1 mutations (Zhou et al., 2012, 
Thongthip et al., 2016, Lachaud et al., 2016). Our work supports that the main function of the 
SMC5/6 complex is in the response to topological stress and that compromised 
topoisomerase function, rather than deficiencies in ICL-repair as previously thought, are the 
cause of KIN.   
 
 
1 - Impact of Nsmce2 deletion on mouse physiology 
1.1 - The SMC5/6 complex suppresses cancer and ageing in mammals 
Whereas the SMC5/6 complex has been subject of intensive research in yeast, its role in 
mammals has been less investigated. Previous to our work, two mouse models with 
mutations in SMC6 were described. Mice carrying an exon trap in the Smc6 allele that 
abrogates the expression of the full-length SMC6 were generated by Ju et al. (2013). In 
agreement with our findings, loss of SMC6 was also embryonic lethal in mice. The same 
study reported that a mutation compromising the ATPase activity of SMC6 has in contrast no 
obvious impact in mouse physiology. 
The lethality of Nsmce2 deletion does not originate from the destabilization of the SMC5/6 
complex, since we have also found that the complex is still able to form even in the absence 
of NSMCE2 (Jacome et al., 2015). Also, NSMCE2 deficiency does not affect the overall 
levels of chromatin bound SMC5/6 proteins. It is still possible that NSMCE2 might regulate 
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the recruitment of the SMC5/6 complex at particular regions. In this regard, an in-depth 
analysis of how Nsmce2 deletion affects the genomewide distribution of SMC5/6 may 
provide insights in the understanding of how the SMC5/6 function is impaired. Alternatively, 
while NSMCE2 might be dispensable for the recruitment of SMC5/6 to its substrates, it might 
be important for its function. These are all still unresolved questions and while we know that 
the SUMO ligase activity is not the main determinant of the functions of NSMCE2, we do not 
know what or how NSMCE2 does to promote the functionality of the SMC5/6 complex. 
In vivo, our work revealed that Nsmce2 deletion in adult mice leads to accelerating ageing. In 
contrast, Nsmce2 heterozygous mice are more prone to develop various types of cancer 
(Jacome et al., 2015) (Figure 1). It so seems that while minor deficiencies in the complex 
can lead to malignancies, more severe mutations can lead to more severe physiological 
manifestations including accelerated ageing. The observation that the transition between 
cancer and aging depends on the severity of the mutation has been also reported for other 
pathways involved in genomic maintenance, including replication stress and the NER 
pathway (López-Contreras and Fernandez-Capetillo, 2010, Diderich et al., 2011).  
  
 
 
 
 
 
 
 
Fig. 1 - Impact of NSMCE2 levels on mouse physiology. 
The transition between cancer and aging depends on the severity of the mutation. Whereas depletion of 
NSMCE2 in mice leads to accelerating ageing, reduced levels of the protein promote cancer 
development. Loss of NSMCE2 abrogates completely the proliferative ability of cells that undergo 
senescence. Residual activity of NSMCE2, although allowing proliferation, cannot promote an efficient 
repair of DNA damage. Hence, reduced NSMCE2 levels leads to increased chromosomal rearrangement 
and thus to cancer development. 
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We propose that the increased recombination rates linked to reduced NSMCE2 levels could 
be the source of cancer-initiating chromosomal rearrangements. In support of this, Mms21 
and Smc6 were found as key factors in suppressing gross chromosomal rearrangements in 
S. cerevisiae (Albuquerque et al., 2013, De Piccoli et al., 2006). In addition, the SMC5/6 
complex itself has been found in regions that are frequently rearranged in human leukaemias 
(Barlow et al., 2013), and fusions occurring at the NSMCE2 locus have also been described 
in acute myeloid leukaemia (Chinen et al., 2014). To what extent these fusions and 
rearrangements compromise the function of the SMC5/6 complex and play a role in 
carcinogenesis is still not known. 
In what regards to ageing, the most likely explanation is that this is due the major 
chromosome segregation problems that arise upon Nsmce2 deletion, which will lead to the 
elimination of many of the cells in the adult mice. As observed in other mouse models of cell 
essential genes such as Atr (Ruzankina et al., 2007), the death of the mutant cells leads to a 
compensatory proliferation of the remaining wild-type cells, finally leading to the exhaustion 
of the regenerative capacities of the stem cells and ultimately ageing (Figure 2). In addition 
to this, it is also possible that the accumulation of abnormal cells also plays a causal role in 
ageing. Accordingly, our present study shows that NSMCE2 deficiency leads to a distinct 
accumulation of polyploidy cells in the kidneys. Such a cell-type specific pattern has also 
been described in other mutations of DNA repair genes that promote progeria. For example, 
one of the most-studied models of progeria, linked to ERCC1 deficiency, also shows a 
preferential accumulation of abnormal cells in the liver (McWhir et al., 1993, Weeda et al., 
1997). 
Besides ageing, NSMCE2 deficiency results in a series of phenotypes that are also found in 
patients with other genomic instability syndromes. For instance, NSMCE2 deficiency leads to 
a significant increase in micronuclei, reduced fat percentage, altered pigmentation and mild 
anemia, which are characteristic of Bloom’s Syndrome (de Renty and Ellis, 2017, German et 
al., 1974). In addition, the bone marrow failure and sensitivity to crosslinking agents that 
occurs upon NSMCE2 loss are also hallmarks of Fanconi anemia. As mentioned above, the 
severity and diversity of these phenotypes are common in mutations that compromise 
genomic stability. Along these lines, two human patients presenting reduced levels of 
NSMCE2 were also recently described (Payne et al., 2014). Similarly to our mouse model, 
these patients presented dwarfism, altered pigmentation, and increased micronuclei. 
Although these individuals did not show evident hallmarks of accelerating ageing, one of 
them died at the age of 33 from a sudden cardiovascular event. Of note, the milder 
phenotype observed in these two patients is likely due to the nature of the deficiency. 
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Whereas in our case we are studying the effects of Nsmce2 nullyzygosity, both patients 
retain small levels of NSMCE2 expression.  
 
 
 
 
 
 
 
1.2 - The SUMO ligase activity of NSMCE2 is dispensable in mice  
Our work illustrates that the essential functions of the SMC5/6 complex in mammals are 
independent of the SUMO ligase activity of NSMCE2. Indeed, NSMCE2 SUMOylation-
deficient mice display a normal lifespan, whereas loss of the protein is embryonic lethal. 
Fig. 2 - The SMC5/6 complex suppresses ageing by promoting accurate chromosome 
segregation. 
Loss of NSMCE2 results in a series of segregation defects (micronuclei, DNA bridges and 
polyploidy) that impair cell growth, thus leading to accelerating cells in mice.  
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Likewise, no proliferation defects are displayed by cells deficient for NSMCE2 catalytic 
activity, while cells can only undergo limited rounds of cell divisions upon loss of NSMCE2. 
Similarly, the Nse2 protein is essential for viability in yeasts, whereas its SUMO ligase 
activity is not (Andrews et al., 2005, McDonald et al., 2003, Xaver et al., 2013). One possible 
explanation, is that since SUMOylation is a rather redundant process the loss of 
NSMCE2‐dependent SUMOylation could be compensated by alternative SUMO ligases. In 
support of this, the minor defects observed in SUMO-dead yeast strains are significantly 
aggravated when additional SUMO ligases are deleted (Albuquerque et al., 2013, Cremona 
et al., 2012). Moreover, although SUMOylation-deficient yeast strains are viable, they display 
hypersensitivity towards DNA damaging agents and aberrant chromosome segregation 
(Andrews et al., 2005, McDonald et al., 2003). Our observation on the dispensability of 
NSMCE2 SUMO ligase activity have been made in mice upon unchallenged conditions. 
However, we cannot discard that the SUMO ligase activity of NSMCE2 may become more 
relevant in the context of DNA damage. We should note, however, that SUMO ligase 
deficient mice are fertile, and meiosis involves a significant amount of DNA damage. 
Moreover, a recent report has shown that conditional deletion of SMC5 is essential for 
meiosis in oocytes (Hwang et al., 2017). Finally, and although the link between the SMC5/6 
complex and SUMOylation appears independent of NSMCE2 activity, the complex may still 
retain some functions that are related to SUMO. For instance, it has been recently proposed 
that the SMC5/6 complex may act as a platform for SUMO, in order to bring SUMO where 
needed, such as sites of DNA damage (Bustard et al., 2016).  
 
2 - The SMC5/6 complex suppresses recombination and facilitates 
chromosome segregation 
The most evident cellular consequence of not having NSMCE2 is a remarkable growth 
impairment. For instance, while NSMCE2-deficient B-lymphocytes can undergo a few cell 
divisions ex vivo, they also present a high rate of cell death and the segregation problems 
leading to polyploidy. Also, MEFs become rapidly senescent after a few divisions upon 
Nsmce2 deletion and also present major segregation problems. Of note, a recently 
developed Smc5 conditional knockout allele has also observed major segregation problems 
in somatic and meiotic cells (Hwang et al., 2017). The ability to undergo some cell divisions 
in the absence of NSMCE2 suggests that problems build up throughout subsequent cell 
cycles until the damage is severe enough to trigger cell-death and/or senescence. 
Additionally, given that Nsmce2 heterozygous tumours always retain the wild‐type allele 
(Jacome et al., 2015) and that NSMCE2 is also required for the proliferation of immortalized 
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MEFs, it seems likely that the SMC5/6 complex is also indispensable for the viability of 
cancer cells.  
In absence of NSMCE2, overall replication occurs at a comparable rate to that of wild-type 
cells. We can, however, not rule out that replication at certain loci, such as at repeated 
regions, is affected by deficiencies in SMC5/6. The repetitive nature of these loci might lead 
to topological stress and/or DNA breakage later on depending on SMC5/6 for its resolution. 
In support of this, several studies demonstrated the localization of the different components 
of the SMC5/6 complex at repetitive sequences, including natural replication pausing sites, 
centromeres and telomeres (Ampatzidou et al., 2006, Lindroos et al., 2006, Menolfi et al., 
2015, Pebernard et al., 2008). Moreover, while restriction of the SMC5/6 complex expression 
to G2-M had no effect on overall origin firing and replication fork speed in yeast, it played a 
role on the replication of natural pausing sites (Menolfi et al., 2015).  
Besides of any role of DNA replication, several studies have suggested that the complex 
participates in DSBs repair through homologous recombination (HR). However rather than 
participating in the actual repair process at all DNA breaks, as proposed by many of these 
works, we propose that the role of SMC5/6 in response to DSBs is linked to the generation of 
joint DNA molecules that might arise as by-products of the repair process at some DSBs. 
Thus, the role of SMC5/6 would be a later one, perhaps involved in the dissolution of 
entangled DNA molecules that reach mitosis, and that can arise during DNA repair. 
Consistently, expression of Smc6 in mitosis is sufficient for the removal of the recombination 
molecules previously accumulated in Smc6 mutant yeast (Bermúdez-López et al., 2010). In 
any case, the fact that at least a subset of the joint DNA molecules that accumulate in 
SMC5/6 mutants depend on RAD51, argues that they are indeed generated during HR repair 
(Ampatzidou et al., 2006, Branzei et al., 2006, Bermúdez-López et al., 2010, Yong-Gonzales 
et al., 2012, Torres-Rosell et al., 2005). 
Rather than seen a decrease in HR, and in agreement with previous reports (Prakash and 
Prakash, 1977, Kliszczak et al., 2012, Ju et al., 2013), our results show that NSMCE2 
deficiency in mouse cells leads to increased recombination rates as detected by SCEs. We 
believe that this is secondary to the accumulation of joint DNA molecules. The elimination of 
these entanglements is mediated either by the dissolution pathway involving the BLM 
helicase, or through a nuclease-dependent pathway known as resolution (Mankouri et al., 
2013, Matos and West, 2014). When dissolution fails, as in BLM deficient cells, the only 
pathway left is resolution leading to the breakage of joint DNA molecules and SCE events. 
This recombination phenotype can be reverted by the abrogation of MUS81 function, thus 
confirming that SCE is resolution-dependent event in these cells (Jacome et al., 2015, Xaver 
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et al., 2013). The MUS81-dependent increase in SCEs observed in NSMCE2-deficient cells 
would suggest that its role is analogous to that of BLMs. 
Since mutations in the SMC5/6 complex resemble BLM deficiencies, it has been 
hypothesized that these factors could work together in order to promote HJ dissolution. In 
fact, NSMCE2 deficiency in mice recapitulates some of the characteristics of BLM patients. 
This similarity between SMC5/6 and BLM was previously noted in several yeast studies.  For 
example, yeast mutants of sgs1, the orthologue of BLM, also accumulate recombination 
intermediates in a RAD51-dependent manner (Liberi et al., 2005, Bermúdez-López et al., 
2016, Branzei et al., 2006, Bonner et al., 2016). Despite the resemblance of BLM and 
NSMCE2 phenotypes, early studies in yeasts failed to link the activity of the SMC5/6 
complex to the one of Sgs1 (Branzei et al., 2006). However, more recently, a physical 
interaction between Smc5 and sgs1 was demonstrated in yeasts (Bonner et al., 2016, 
Bermúdez-López et al., 2016). The purpose of this interaction resides in the SUMOylation of 
the three components of the BTR complex. The SUMOylation of the BTR complex is partially 
dependent on Mms21 activity and it is essential to counteract the accumulation of DNA joint 
molecules (Bermúdez-López et al., 2016, Bonner et al., 2016). Even if SUMOylation 
deficiency is not pathological in mice, this does not discard the possibility that BLM and 
SMC5/6 work on the resolution of a common problem. In agreement with this, the deletion of 
BLM in combination with NSMCE2 deficiency is synthetic lethal in mammalian cells (Jacome 
et al., 2015) and in yeast (Chen et al., 2009). In addition, double mutant yeasts accumulate 
further DNA joint molecules in mitosis (Torres-Rosell et al., 2005) and meiosis (Xaver et al., 
2013, Copsey et al., 2013). 
 
3 - NSMCE2 and TOPO2 work together to ensure chromosome segregation  
Our data supports that one of the key functions held by the SMC5/6 complex involves the 
cooperation with TOPOII in dealing with topological problems arising from chromatin 
transactions. Due to the intrinsic nature of DNA, chromatin processes such as replication, 
transcription and repair can generate topological problems during the unwinding of the 
duplex DNA and the exposure of ssDNA. Topoisomerases are the best-established 
component in limiting topological stress. In particular, TOPOII works by the introduction of a 
transient DSB, followed by a DNA conformational change to eliminate the supercoil and the 
relegation of the ssDNA ends (Nitiss, 2009). Today, many lines of evidence support that the 
role of the SMC5/6 complex is linked to TOPOII. 
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TOPOII deficiency is embryonic lethal in yeast (Holm et al., 1985, Uemura and Yanagida, 
1984, DiNardo et al., 1984) and mice (Akimitsu et al., 2003). Interestingly, embryos lacking 
TOPOII present the same mitotic abnormalities that we could observe in early NSMCE2-
deficient embryos (Jacome et al., 2015). Moreover, segregation deficiencies in NSMCE2-
deficient MEFs seem to preferentially involve pericentromeric DNA, which is the largest 
repeat of the mammalian genome. Likewise, loss of TOPOII results in failure of centromeric 
disjunction, with an increased rate of segregation defects including DNA bridges and lagging 
chromosomes (Coelho et al., 2008, Bower et al., 2010). ChIP-seq analysis further supports 
the resemblance of SMC5/6 and TOPOII. These studies have revealed that SMC5/6 
localizes preferentially associates with repeated regions in yeast like centromeres or 
ribosomal DNA (Lindroos et al., 2006, Jeppsson et al., 2014). In the case of TOPOII, it is well 
known that it is particularly relevant for the segregation of centromeric regions (Rattner et al., 
1996, Christensen et al., 2002), and our immunofluorescence analyses support such a 
dominant role since TOPOII is particularly enriched around pericentromeric DNA. Moreover, 
upon TOPOII inhibition NSMCE2 rapidly relocalizes to heterochromatin, further supporting a 
coordinated role of these complexes in dealing with topological stress. Finally, the link to 
TOPOII is further suggested by the finding of diplochromosomes in the metaphases of 
Nsmce2 knockout MEFs, an event that is also induced by TOPOII is inhibition (Sumner, 
1998, Ji et al., 2009, Cortés and Pastor, 2003).  
The many similarities of TOPOII and NSMCE2 deficiencies argue for a similar function of 
these factors, but how they work together, if they do, is still unclear. A model for TOPOII-
SMC5/6 interaction was proposed by Kegel et al. (2011). According to this study, the 
SMC5/6 complex would reduce the superhelical tension ahead of the replication fork by 
promoting fork reversal (Figure 3). Fork reversal would then generate sister chromatids 
interwinings (SCIs) which are known substrates for TOPOII. Therefore, the function of the 
SMC5/6 complex would reside in the generation of DNA substrates with the appropriate 
conformation for TOPOII resolution. This view is supported by the accumulation of SCIs in 
top2-4 mutant yeasts, since TOPOII is necessary to dissolve these structures. Moreover, this 
increase in SCIs is reduced in smc6-56 top2-4 double mutant, supporting the role of the 
SMC5/6 complex in fork reversal-mediated generation of SCIs (Kegel et al., 2011). 
Several reports have demonstrated a genetic interaction between the SMC5/6 complex and 
TOPOII in yeasts (Takahashi et al., 2008, Outwin et al., 2009, Jeppsson et al., 2014). The 
synthetic lethality observed in these mutants suggests that both complexes might deal 
independently in the resolution of HJs. In support of this, and while TOPOII and NSMCE2 
colocalize at foci, we failed to see a direct interaction between these complexes by IP. We 
shall note that a recent manuscript has reported a coIP between TOPOII and SMC5, but this 
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is something we cannot reproduce (Verver et al., 2016). In any case, both our work and this 
manuscript revealed an increased sensitivity of SMC5/6 mammalian mutants to TOPO 
inhibition, providing the first evidences of a synthetic lethal interaction of TOPOII and 
SMC5/6 in mammalian cells. 
 
 
 
 
 
 
As regards the type of lesion recognised by the SMC5/6 complex, it seems clear 
recombination intermediates are not the only substrates and other will likely be sites of 
Fig. 3 - The SMC5/6 promotes fork reversal and generates TOPOII-competent substrates. 
Modified from Kegel and Sjogren (2010). 
DNA replication generates positive supercoiled DNA ahead of the fork. Mainly Top1, but also Top2, 
alleviates this superhelical tension in order to allow fork progression. The SMC5/6 complex might promote 
fork reversal that generates SCIs. Top2 plays a central role in removing these catenates.  
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topological stress. Accordingly, top2 deletion in yeast leads to a redistribution of Smc6 along 
the chromosome arms that is independent of recombination. Moreover, no recombination 
intermediates were identified in regions where SMC5/6 accumulates in the absence of 
TOPOII (Jeppsson et al., 2014). Instead of sites of recombination, and since deficiencies in 
TOPOII result in SCIs accumulation, SMC5/6 association to chromatin may be triggered by 
SCIs in these mutants (Figure 3). In absence of TOPOII, the SMC5/6 complex may facilitate 
the resolution of SCIs, however not as efficiently as when TOPOII is present. The SMC5/6 
complex might be able to recognise distinct structures that perturb chromatin architecture. 
SCIs and recombination intermediates must share some structural features able to trigger 
the association of the complex.  
To end, we should end by noting that the similar phenotype of FAN1 and NSMCE2 
deficiency in mice, namely the appearance of KIN, could suggest that FAN1 might participate 
in the response to topological stress. This is interesting since even if FAN1 was first 
associated to ICL-repair, FAN1 mutant patients do not have Fanconi Anemia (Lans and 
Hoeijmakers, 2012, Zhou et al., 2012, Trujillo et al., 2012) and the only phenotype that they 
present is KIN. Moreover, the ICL-repair defect of FAN1-deficient cells is modest, raising 
doubts of what is the real substrate of this nuclease. The resemblance of the phenotypes 
could suggest that FAN1’s true substrates are HJs or other sites of topological stress. While 
in an initial experiment we failed to observed a distinctively high toxicity of TOPOII inhibitors 
in FAN1-deficient cells, this line of work deserves further exploration in depth (see below). 
 
4 - Karyomegalic interstitial nephritis as a result of topological problems  
Here we report the second mutation, after FAN1 that can lead to KIN in mammals. Once 
again, the role of NSMCE2 in KIN is independent of its SUMO ligase activity, further 
illustrating that NSMCE2 plays important functions in SMC5/6 besides its SUMO ligase 
activity. Our data, together with evidence provided by other studies, suggest that KIN is a 
consequence of the accumulation of topological stress that ultimately leads to polyploidy 
(Figure 4). Our view that KIN is linked to topological stress is supported by the fact that in 
human patients, KIN was found to be primarily associated to the contact with the mycotoxin 
OTA (Hassen et al., 2004, Godin et al., 1996), which was later found to inhibit TOPOII 
(Cosimi et al., 2009). Furthermore, TOPOII expression is distinctively high in karyomegalic 
cells found in the renal tubuli (Adler et al., 2009). Similarly, NSMCE2 deficiency in MEFs 
produces a pronounced accumulation of TOPOII at centromeres. Moreover, many reports 
have shown a genetic relationship between the SMC5/6 complex and TOPOII (Jeppsson et 
al., 2014, Kegel et al., 2011, Takahashi et al., 2008, Outwin et al., 2009).  
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As mentioned, mutations in the FAN1 nuclease are the only known cause of hereditary KIN 
in humans (Zhou et al., 2012, Lachaud et al., 2016, Thongthip et al., 2016). Since early 
studies linked the activity of FAN1 to the FA pathway (Smogorzewska et al., 2010, MacKay 
Fig. 4 - Topological stress can trigger the onset of KIN. 
OTA and NSMCE2 deficiency induce KIN by altering the activity of TOPOII. Whereas OTA is able inhibit 
topoisomerase activity in vitro, NSMCE2 loss triggers a significant association of TOPOII to centromeres.  
The link with topological stress is still unclear for mutations in the nuclease FAN1, also associated to KIN 
phenotype in mammals. 
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et al., 2010), it was proposed that FAN1 could participate in the repair of ICLs and that the 
KIN phenotype would arise from the defective repair of these DNA lesions. However, the 
clinical outcome of FAN1 deficiencies and FA differs significantly. Individuals carrying 
mutations in FAN1 are negative for FA testing and they do not develop anemia (Lans and 
Hoeijmakers, 2012, Zhou et al., 2012, Trujillo et al., 2012). Moreover, no evidences of KIN 
have been found in the kidneys from FA patients and FA mouse models. The evaluation of 
the epistatic relation of FAN1 with the FA proteins FANCD2 and SLX4 have further 
suggested a minor role for FAN1 in the ICL repair pathway (Thongthip et al., 2016, Lachaud 
et al., 2016). These observations suggest that KIN development is not strictly connected to 
deficiencies in ICL repair, but other mechanism, for instance topological stress, could trigger 
the disease.  
The fact that catalytic inhibitors of TOPOII promote robust FAN1 foci shows, for the first time, 
that FAN1 plays a role in the response to topological problems. In fact, the inhibition of 
TOPOII generates a more severe lesion that recruits FAN1 in a greater number of cells than 
ICL-inducing agents. Whereas in a first attempt we failed to detect an obvious sensitivity of 
FAN1-deficient cells to TOPOII inhibition, this needs to be further addressed in other cell 
types and experimental conditions. It is also possible that the role of NSMCE2, and thus of 
SMC5/6 is more critical than that of FAN1. In fact, the KIN that occurs upon Fan1 deletion in 
mice is significantly milder than what we see in NSMCE2-deficient mice (Thongthip et al., 
2016).  While KIN is only fully developed after 1 year in FAN1-deficient mice, we can see 
severely affected kidneys in mice that are five months of age in Nsmce2 mutants. It would be 
interesting to see whether a treatment with OTA or ICRF-193 further accelerates the onset of 
KIN in either of the strains. 
Beside renal disorders, FAN1 deficiency in mice has been also associated to karyomegaly 
and dysfunction in liver (Thongthip et al., 2016). In contrast, we have not identified an 
obvious phenotype in NSMCE2-deficient livers. Why some organs are more affected by a 
mutation than by another one remains enigmatic. It is not surprising however that kidney and 
liver are the most affected organs. These organs are continuously exposed to genotoxic 
insults coming from waste metabolites. For this reason, liver and kidney naturally endure 
higher doses of DNA damage compared to other organs. One possibility is that these organs 
have selected a higher threshold for triggering apoptosis in response to DNA damage, to 
prevent excessive cell elimination due to the contact with toxins. In support of this, it is 
noteworthy that the karyomegaly in KIN is restricted to proximal tubular epithelial cells that 
are in a more direct contact with toxic metabolites, whereas the renal medulla remains 
almost unaffected.  
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In regards to the nature of the KIN-initiating insult, environmental exposure to toxins, such as 
OTA (Hassen et al., 2004, Godin et al., 1996) or various chemotherapeutics (McCulloch et 
al., 2011, Mihatsch et al., 1979, Burry, 1974, Godin et al., 1996) can damage kidneys and 
lead to renal failure. Interestingly, kidneys can also suffer from the products of our own 
endogenous metabolism. Given the increasing evidence that metabolism-generated 
formaldehyde and acetaldehyde able to induce cellular damage, it is possible that aldehydes 
can contribute to KIN pathogenesis. The sensitivity to acetaldehyde and formaldehyde of 
FAN1-deficient cells favour this association (Thongthip et al., 2016). The sensitivity towards 
these compounds upon Nsmce2 deletion would provide further evidence of the link between 
kidney disorders and endogenous genotoxic metabolites. To explore this possibility, in early 
studies of my PhD I attempted to rescue the viability of NSMCE2-deficient MEFs by 
overexpressing ADH5, the main enzyme in formaldehyde catabolism. However, this 
experiment failed, although acknowledgedly we did not pursue this in sufficient depth. A 
genetically cleaner way could be to test if KIN is aggravated ADH5-NSMCE2 double mutant 
mice. If true, this would suggest that the initial insult that triggers KIN, even if this is later 
converted into topological stress, is the presence of formaldehyde. Along these lines, a 
recent study showed the ability of formaldehyde to induce DNA damage in kidneys (Pontel et 
al., 2015). Moreover, and while FANCD2-deficient mice do not suffer from kidney disorders, 
a disease with resemblances to KIN does occur when FANCD2 deficiency occurs in 
combination with ADH5 deletion. Whereas we favour that the role of FAN1 might be more 
linked to topological stress than to ICL-repair, one interesting possibility is that FAN1 could 
be directly involved in the repair of the crosslinks induced by the formaldehyde, whereas the 
role of SMC5/6 could be more associated to HJs that could arise secondarily at ICL sites.  
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Conclusions 
 
 NSMCE2 deficiency is dispensable for overall DNA replication but cell essential due 
to chromosome segregation defects. 
 NSMCE2 suppresses cancer and ageing in mice independently of its SUMO-ligase 
activity. 
 Nsmce2 deletion in adult mice leads to Karyomegalic Interstitial Nephritis (KIN), 
which is characterized by the presence of karyomegalic cells in the cortex of the 
kidneys, ultimately leading to tubular dilation, fibrosis and compromised kidney 
function. 
 The onset of KIN is independent of the SUMO ligase activity of NSMCE2. 
 In addition to its recruitment to sites of DNA damage or interstrand-crosslinks, 
NSMCE2 forms prominent nuclear foci in response to TOPOII inhibition. 
 NSMCE2 deficiency increases the levels of chromatin-bound TOPOII. 
 NSMCE2 deficiency phenocopies TOPOII inhibition in various aspects such as the 
appearance of diplochromosomes or anaphase bridges involving pericentromeric 
regions. 
 NSMCE2-deficient cells are sensitive to the segregation defects induced by TOPOII 
inhibition.   
 While FAN1 colocalizes with NSMCE2 at sites of topological stress, Fan1 deletion 
does not sensitize MEFs to TOPOII inhibition. 
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Conclusiones 
 
 NSMCE2 no es indispensable para el proceso de replicación del DNA, sin embargo 
resulta esencial para asegurar una correcta segregación cromosómica. 
 NSMCE2 suprime el cáncer y el envejecimiento en ratones independientemente de 
su actividad como SUMO ligasa. 
 La deleción de Nsmce2 en animales adultos produce nefritis intersticial 
cariomegálica, que se caracteriza por la presencia de células cariomegálicas en la 
corteza renal. En último término da lugar a dilatación tubular, fibrosis, y compromete 
la función renal.  
 La aparición de nefritis intersticial cariomegálica es independiente de la actividad 
SUMO ligasa de NSMCE2. 
 Además de acumularse en áreas dañadas del DNA o “interstrand crosslinks”, 
NSMCE2 forma focos nucleares en respuesta a inhibidores de la TOPOII. 
 La deficiencia en NSMCE2 incrementa los niveles de TOPOII unida a cromatina. 
 La deficiencia en NSMCE2 fenocopia la inhibición de TOPOII en varios aspectos, 
como la aparición de diplocromosomas o puentes de cromatina en regiones 
pericentroméricas. 
 Las células deficientes en NSMCE2 son sensibles a los defectos en segregación 
cromosómica inducidos por la inhibición de TOPOII. 
 Mientras FAN1 colocaliza con NSMCE2 en regiones de stress topológico, la deleción 
de Fan1 no conduce a la sensibilización de fibroblastos (MEFs) frente a la inhibición 
de TOPOII. 
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